This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

I honestly had no idea intravenous drips — or IV drips — were a wellness thing until my husband suggested them as a Beyond the Buzz topic.

Then I did a quick Google search, saw them everywhere, and thought: okay, what’s the bottom line here?

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

The names vary, but these businesses are selling overlapping kinds of wellness IV services. [H1,H2,H3]

In Ohio alone, regulators told the Associated Press that the state had around 200 IV therapy clinics in 2025. [H1]

These services are also part of a substantial commercial market. Market research estimated that the U.S. IV hydration therapy market — which includes hydration, energy, immune support, performance and other services — generated just over 1.1 billion dollars in revenue that same year. [H2]

The claims are widespread too. Researchers reviewing 255 IV hydration spa websites across the United States found that all made claims about health benefits, but only two — less than 1 percent — cited sources for those claims. [H3]

So whatever label is used, wellness IV services are highly visible, commercially significant, and making claims that are worth examining more closely. [H1,H2,H3]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence,
how certain can we be, and what does it mean for your decision?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The first thing to know is that the direct evidence for the kind of multi-ingredient vitamin drips sold in wellness clinics is surprisingly sparse. [E1,E9]

A 2020 Canadian evidence review found no relevant studies that could establish whether IV multivitamin therapy works, and no evidence-based guidelines for its use. [E1]

Hydration is a little clearer.

A review comparing IV fluids with drinking fluids in athletes found that IV fluids can restore hydration somewhat faster, but the differences were generally small and short-lived.

It did not find a meaningful performance advantage when athletes were able to drink. [E2]

Fatigue has one interesting signal.

In a study of 141 healthy office workers, participants were randomly assigned to receive either a single IV dose of vitamin C or a salt-water IV used as a placebo. Those who received vitamin C reported less fatigue at two hours and the next day. [E3]

The effect was stronger among people who started with lower vitamin C levels. [E3]

But that is one study of one vitamin, given at one dose.

It does not establish that commercial multi-ingredient drips broadly improve fatigue. [E3]

For hangovers, a review brought together 21 studies involving 386 participants that compared different hangover treatments with placebo. No two studies tested the same treatment, and the evidence for all of them was rated very low quality. [E4]

None tested a commercial IV drip, so the review cannot tell us whether an IV hangover drip works better than drinking fluids or doing nothing. [E4]

And for immune support, there is no high-quality evidence that IV vitamin infusions provide health benefits in generally healthy adults. [E9]

There is also a trade-off that oral options do not have: an IV is a medical procedure. [E5]

A large review found that problems with IV lines were not rare in health-care settings. [E5]

And in one Texas med-spa case, a patient died after an unlicensed person administered IV therapy containing prescription drugs, in a setting with inadequate medical supervision and emergency procedures. [E8]

That single case does not tell us how often serious harm occurs, but it reinforces that having an IV — and how it is delivered — is not risk-free. [E5,E8]

None of this means IV therapy itself is questionable medicine.

UK clinical guidelines recommend IV fluids when a patient’s fluid needs cannot be met by drinking or through a feeding tube, and stopping them once they are no longer needed. [E6]

European clinical nutrition guidelines likewise note that nutrients can be given through an IV when absorption is poor or a deficiency needs to be corrected quickly. [E7]

That is very different from choosing a wellness drip when you are generally healthy. [E6,E7]

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be how direct it feels.

An IV can seem more substantial than drinking water or taking a pill.

It can also feel efficient: one appointment, one bag, one visible intervention.

And when something is presented in a medical-looking setting, the experience itself may feel reassuring or purposeful.

The promise is easy to understand — more direct, more immediate, more done-for-you.

That emotional logic can be compelling even before we ask whether the added step actually adds meaningful value.

🧭THE TAKEAWAY

Here’s your Evidence Clarity moment.

So what’s the takeaway?

For generally healthy adults, consumer wellness IV drips have not been shown to deliver the broad benefits they are marketed for or to provide a clear overall advantage over simpler oral options. [E1,E2,E4,E9]

There are narrower findings worth keeping in view — including a short-term fatigue benefit from one IV vitamin C trial — but they do not establish that typical multi-ingredient wellness drips broadly improve fatigue, hangovers, immune support,
hydration, or recovery. [E1,E2,E3,E4,E9]

This matters because the intervention also involves an IV procedure, while direct evidence on the actual commercial drips remains limited. [E1,E5]

Before paying for one, it may help to ask two separate questions: what am I hoping for, and is there good evidence that an IV gives me a meaningful advantage for that outcome over a simpler option?

For wellness IV drips, faster delivery is not the same thing as proven added benefit. [E2,E9]

💭REFLECTION PROMPT

Something to reflect on…

If a wellness treatment feels more powerful because it looks medical, what evidence would you want before deciding it is worth your time, money, and attention?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious.

This is Beyond the Buzz — I do the research so you don’t have to.

Next week: Can Bond-Repair Treatments Really Fix Damaged Hair?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
The Associated Press. (2025). Thinking about taking a stab at IV therapy? Ask some questions first. The Associated Press. https://apnews.com/article/retail-iv-therapy-drip-hydration-e335f09bc013739aa69fa43d92bc4945 June 30, 2025.

H2
Grand View Research. (2025). U.S. Intravenous (IV) Hydration Therapy Market Size & Outlook. Grand View Research. https://www.grandviewresearch.com/horizon/outlook/intravenous-iv-hydration-therapy-market/united-states Date of statistic: 2025; 2025 is the base year.

H3
Sivakumar, A., Forman, H. P., Wang, I., Lurie, P., & Ross, J. S. (2025). State Policies and Facility Practices of IV Hydration Spas in the US. JAMA Internal Medicine, 185(12), 1455–1461. https://doi.org/10.1001/jamainternmed.2025.5028 🔒

E1
Wells, C., Butcher, R., & McCormack, S. (2020). Intravenous Multivitamin Therapy Use in Hospital or Outpatient Settings: A Review of Clinical Effectiveness and Guidelines. Canadian Agency for Drugs and Technologies in Health. CADTH Rapid Response Report: Summary with Critical Appraisal; Version: 1.0. https://www.ncbi.nlm.nih.gov/books/NBK567072/ 🔓

E2
van Rosendal, S. P., Osborne, M. A., Fassett, R. G., Lancashire, B., & Coombes, J. S. (2010). Intravenous versus Oral Rehydration in Athletes. Sports Medicine, 40(4), 327–346. https://doi.org/10.2165/11319810-000000000-00000 🔒

E3
Suh, S.-Y., Bae, W. K., Ahn, H.-Y., Choi, S.-E., Jung, G.-C., & Yeom, C. H. (2012). Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial. Nutrition Journal, 11, 7. https://doi.org/10.1186/1475-2891-11-7 🔓

E4
Roberts, E., Smith, R., Hotopf, M., & Drummond, C. (2022). The efficacy and tolerability of pharmacologically active interventions for alcohol‐induced hangover symptomatology: A systematic review of the evidence from randomised placebo‐controlled trials. Addiction, 117(8), 2157–2167. https://doi.org/10.1111/add.15786 🔓

E5
Marsh, N., Larsen, E. N., Ullman, A. J., Mihala, G., Cooke, M., Chopra, V., Ray-Barruel, G., & Rickard, C. M. (2024). Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis. International Journal of Nursing Studies, 151, 104673. https://doi.org/10.1016/j.ijnurstu.2023.104673 🔓

E6
National Institute for Health and Care Excellence. (2013). Intravenous fluid therapy in adults in hospital. National Institute for Health and Care Excellence. Clinical guideline CG174; last updated 5 May 2017. https://www.nice.org.uk/guidance/cg174 🔓

E7
Berger, M. M., Shenkin, A., Schweinlin, A., Amrein, K., Augsburger, M., Biesalski, H.-K., Bischoff, S. C., Casaer, M. P., Gundogan, K., Lepp, H.-L., de Man, A. M. E., Muscogiuri, G., Pietka, M., Pironi, L., Rezzi, S., & Cuerda, C. (2022). ESPEN micronutrient guideline. Clinical Nutrition, 41(6), 1357–1424. https://doi.org/10.1016/j.clnu.2022.02.015 🔓

E8
Texas Medical Board. (2024). TMB disciplines 22 physicians at August meeting. Texas Medical Board. Official disciplinary-action press release summarizing an Agreed Order entered August 16, 2024. September 6, 2024. Texas Medical Board — TMB disciplines 22 physicians at August meeting 🔓

E9
Intravenous vitamin injections: where is the evidence? (2023). Drug and Therapeutics Bulletin, 61(10), 151–155. https://doi.org/10.1136/dtb.2023.000006 🔒

🎧 Prefer to listen?
Listen to Do IV Vitamin Drips Actually Work? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

My college-aged son occasionally takes creatine with his gym buddies.

It made me wonder two things: is it actually worth him spending money on —
and, since I’m in midlife and do regular strength training, is it something I should consider too?

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Creatine is clearly having a moment.

Retail sales were up 56% year over year, and the global creatine-supplements market was estimated at 1.7 billion U.S. dollars in 2026. [H1,H2]

However, in a 2026 survey of current or recent creatine users, only 55% said they perceived a benefit, even though 98% intended to keep taking it. [H3]

So popularity, spending, and perceived value are not automatically the same thing.

When does creatine actually earn its place in a routine? [H1,H2,H3]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence,
how certain can we be, and what does it mean for your decision?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

For strength and power, creatine monohydrate has a real evidence base.

A 2025 meta-analysis — which pools results across studies — found benefits across several strength and power outcomes, with more consistent results in younger adults and men.

In younger adults, creatine was associated with about six and a half kilograms more improvement in squat strength and eight kilograms more in leg press than the groups they were compared with.

Those are average additional gains across studies of varying lengths — not an instant boost or a prediction of what any one person will lift. [E1]

Creatine is an add-on, not a substitute for training.

Research on body composition shows that training matters, especially when the goal is increasing lean mass — which includes muscle and body water — rather than simply seeing the scale move. [E2]

And the scale can move for different reasons.

The U.S. National Institutes of Health notes that people using creatine during strength training may gain about one to two kilograms in a month.

Some early weight gain can be water, especially with a loading phase.

Water retention tends to be most noticeable in the first several days
and does not consistently persist in longer-term studies.

Over time, especially with strength training, some of the additional weight can also reflect increases in muscle. [E2,E7,E8]

Creatine is typically taken every day.

A usual daily dose is three to five grams.

Loading — about 20 grams a day, divided into four smaller doses for five to seven days — raises muscle creatine stores faster, but it is optional.

You can simply take the smaller daily dose consistently
and get there more gradually. [E7]

That brings me back to the midlife question.

For postmenopausal women, a 2026 meta-analysis also found benefits,
particularly when creatine was combined with strength training.

In three trials involving 111 women, lasting roughly three months to a year, creatine was associated with about seven and a half kilograms more improvement in leg-press strength than in women who received a placebo without creatine. [E3]

The review concluded that benefits were particularly evident with at least five grams a day alongside strength training. [E3]

So for postmenopausal women, the strength story is promising, especially alongside strength training, but there are still relatively few studies. [E3]

But what if the goal isn’t strength?

For endurance, a meta-analysis in trained people did not show a clear overall improvement in endurance performance. [E4]

If your main goal is steady running or cycling performance, creatine therefore has a weaker case than it does for strength, power, or repeated high-intensity work. [E4,E7]

Then there’s the question of brain health.

The brain-health claims are also ahead of the evidence.

The European Food Safety Authority reviewed the evidence and concluded that a cause-and-effect relationship between creatine and improved cognitive function — things like memory, attention, or problem-solving — had not been established. [E5]

That leaves room for further study, but not for a broad claim that creatine improves cognition or brain health in everyday use. [E5]

Then there’s the other side of the decision: what are the downsides or risks of taking it?

On kidney safety, a review of the research did not find evidence that creatine damages kidney function in the people studied, although creatinine — a blood marker used when assessing kidney function — can rise and needs context. [E6]

For generally healthy adults taking the doses that have been studied, the broader safety picture is reassuring. [E6,E7]

There’s also the question of what’s actually in the product you buy.

Independent certification can provide extra assurance that a supplement contains the ingredients and amounts listed on the label. [E7]

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that creatine feels concrete.

You can buy it, scoop it, take it, and connect it to a goal.

It can also land differently by life stage.

For a younger person, it may feel like part of gym culture.

In midlife, the same product can start sounding like a way to make strength training count for more.

And once one supplement appears in conversations about performance, muscle, aging, and the brain, it is easy to wonder whether you are missing something by not taking it.

🧭THE TAKEAWAY

Here’s your Evidence Clarity moment.

So what’s the takeaway?

Yes — creatine monohydrate works, with its clearest case for people whose goal is strength or power and who are doing strength training or other high-intensity exercise. [E1,E2,E7]

The strength results have been more consistent in younger adults and men, but postmenopausal women also appear to benefit when creatine is combined with strength training — although there is less research in postmenopausal women. [E1,E3]

It is less convincing for endurance performance, and the evidence does not support treating it as a proven cognitive or general anti-aging supplement. [E4,E5]

For someone deciding whether it is worth the money and effort, the useful question is not simply, “Does creatine work?”

It is, “Does the outcome it is most likely to improve actually match my goal?”

For my son, that shifts the question away from whether his gym buddies take it
and toward whether his own training goals make the likely benefit worth paying for.

For me, the decision is pretty practical: am I willing to pay for and take five grams of creatine every day alongside my strength training for the possibility of a modest additional strength gain?

In the postmenopausal studies, the average advantage was about seven and a half kilograms more improvement in leg press — but that is an average, not a prediction of what I would gain. [E3]

Match creatine to the outcome you want, not the size of the buzz.

💭REFLECTION PROMPT

Something to reflect on…

When you think about a supplement you take — or are considering — are you clear about the specific outcome you want from it?

And would an additional improvement in that outcome actually be worth the cost, effort, and trade-offs for you?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious.

This is Beyond the Buzz — I do the research so you don’t have to.

Next week: Do IV Vitamin Drips Actually Work?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
SPINS. (2026). Creatine, Industry Watch. SPINS. https://www.spins.com/industry-watch/creatine/ Published July 1, 2026; statistic observed on August 19, 2026.

H2
Grand View Research. (2026). Creatine Supplements Market Size, Share Report 2026–2033. Grand View Research. https://www.grandviewresearch.com/industry-analysis/creatine-supplements-market-report Report published June 2026; last updated July 2026.

H3
Burridge, J., Boolani, A., Zhang, Z., & Glenn, J. M. (2026). Real-world creatine supplementation: a large-scale cross-sectional study of use, knowledge, and experiences. Journal of the International Society of Sports Nutrition, 23(1), 2702952. https://doi.org/10.1080/15502783.2026.2702952 🔓

E1
Kazeminasab, F., Bahrami Kerchi, A., Sharafifard, F., Zarreh, M., Forbes, S. C., Camera, D. M., Lanhers, C., Wong, A., Nordvall, M., Bagheri, R., & Dutheil, F. (2025). The Effects of Creatine Supplementation on Upper- and Lower-Body Strength and Power: A Systematic Review and Meta-Analysis. Nutrients, 17(17), 2748. https://doi.org/10.3390/nu17172748 🔓

E2
Pashayee-Khamene, F., Heidari, Z., Asbaghi, O., Ashtary-Larky, D., Goudarzi, K., Forbes, S. C., Candow, D. G., Bagheri, R., Ghanavati, M., & Dutheil, F. (2024). Creatine supplementation protocols with or without training interventions on body composition: a GRADE-assessed systematic review and dose-response meta-analysis. Journal of the International Society of Sports Nutrition, 21(1), 2380058. https://doi.org/10.1080/15502783.2024.2380058 🔓

E3
Naddafha, S., Antonio, J., Kreider, R. B., & Stout, J. R. (2026). Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis. Journal of the International Society of Sports Nutrition, 23(1), 2668435. https://doi.org/10.1080/15502783.2026.2668435 🔓

E4
Fernández-Landa, J., Santibañez-Gutierrez, A., Todorovic, N., Stajer, V., & Ostojic, S. M. (2023). Effects of Creatine Monohydrate on Endurance Performance in a Trained Population: A Systematic Review and Meta-analysis. Sports Medicine, 53(5), 1017–1027. https://doi.org/10.1007/s40279-023-01823-2 🔒

E5
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Cámara, M., Castenmiller, J., de Henauw, S., Hirsch-Ernst, K.-I., Jos, Á., Maciuk, A., Mangelsdorf, I., McNulty, B., Naska, A., Pentieva, K., Thies, F., Craciun, I., Fiolet, T., & Siani, A. (2024). Creatine and improvement in cognitive function: Evaluation of a health claim pursuant to article 13(5) of regulation (EC) No 1924/2006. European Food Safety Authority (EFSA). Scientific Opinion; EFSA Journal 22(11):e9100. https://doi.org/10.2903/j.efsa.2024.9100 🔓

E6
de Souza Almeida, A., Dias da Silva, L. O., Takahasi, B. N. A., Terada, B. D., Gonçalves, F. G. A., Porto, B. C., Sardenberg, R. A. da S., Passerotti, C. C., Maia, R. S., Samaan, F., Thoman, M., Molina, W. R., & da Cruz, J. A. S. (2026). Impact of creatine supplementation on kidney health: a systematic review and meta-analysis. International Urology and Nephrology. https://doi.org/10.1007/s11255-026-05287-x 🔓

E7
National Institutes of Health (NIH), Office of Dietary Supplements (ODS). (2024). Dietary Supplements for Exercise and Athletic Performance. National Institutes of Health, Office of Dietary Supplements. Fact Sheet for Health Professionals; Updated April 1, 2024. https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/ 🔓

E8
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., & Ziegenfuss, T. N. (2021). Common questions and misconceptions about creatine supplementation: What does the scientific evidence really show? Journal of the International Society of Sports Nutrition, 18, 13. https://doi.org/10.1186/s12970-021-00412-w 🔓

🎧 Prefer to listen?
Listen to Does Creatine Actually Work — and Who Benefits? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Going gluten-free can seem like a direct answer to digestion, fatigue, brain fog, weight, inflammation, or simply eating better. But if you do not have celiac disease, does removing gluten make the diet healthier — or just different? The choice can feel simple. The answer is not.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

In a U.S. survey fielded in March 2025, 7% of adults ages 18 to 80 said they had followed a gluten-free eating pattern during the previous year. [H1]

The global gluten-free products market was valued at $8.5 billion in 2025 and is projected to reach over $18 billion by 2033. [H2]

And in a 2023 U.S. survey, 49% of adults strongly or somewhat agreed that people who eat gluten-free are generally healthier than people who eat gluten. [H3]

So the question is: is gluten-free actually healthier when there is no medical reason to avoid gluten? [H1,H2,H3]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, celiac disease and wheat allergy are important exceptions. Celiac disease is an immune reaction to gluten that damages the small intestine. Wheat allergy is an allergic reaction to wheat. Avoiding the trigger is medically important in both conditions. [E1,E3]

For people without those conditions, the evidence does not show that removing gluten automatically improves general health. A broad review found that convincing evidence for health benefits outside established gluten-related conditions is lacking. [E3]

One long-term study looked specifically at heart health. Across 26 years of follow-up in more than 100,000 adults without celiac disease, gluten intake was not associated with coronary heart disease. The researchers cautioned that avoiding gluten could mean eating fewer beneficial whole grains. [E5]

Gluten-free also does not mean nutritionally better. Packaged gluten-free replacements are not automatically higher in fibre or nutrients, and some gluten-free diets may provide less fibre, fewer whole grains, or inadequate amounts of certain vitamins and minerals. That can make the diet less nutritionally complete and make it harder to meet everyday nutrient needs, especially when nutritious whole-grain foods are replaced with less nutrient-dense alternatives. [E3,E4,E5]

Symptoms are where the picture gets more complicated. Non-celiac gluten sensitivity, also called non-celiac gluten or wheat sensitivity, is a possible clinical condition, but there is no single diagnostic test and its symptoms overlap with other disorders. [E1]

People may report digestive symptoms, fatigue, or brain fog after eating wheat-containing foods. But gluten may not always be the cause. Other wheat components may contribute, including FODMAPs — short-chain carbohydrates that can trigger gut symptoms in some people. [E1,E2]

For irritable bowel syndrome, or IBS—a condition involving recurring abdominal pain and changes in bowel habits—a systematic review, which evaluates existing research, found that the evidence was not strong enough to support a gluten-free diet. [E2]

Feeling better after removing gluten can be meaningful without proving that gluten was the trigger. When symptoms improve after a diet change, it is natural to connect the two—but timing alone does not establish cause. The improvement could relate to gluten, another wheat component, other foods removed at the same time, or simply symptoms changing by chance. [E1,E2,E3]

Claims about weight, inflammation, fatigue, or brain fog need similar caution. Current evidence does not establish gluten avoidance as a general strategy for improving those outcomes in people without celiac disease. [E1,E3]

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that gluten-free offers one clear rule in a noisy food environment. It gives people something visible to remove and a simple way to explain how they feel.

The message can also feel reassuring because it turns a complicated question into one choice: gluten or no gluten. But that simplicity can pull attention away from the quality of the whole eating pattern or from what is actually causing the symptoms.

That brings us back to the decision itself.

🧭THE TAKEAWAY

Your Evidence Edit moment.
So what’s the takeaway?

For people without celiac disease, wheat allergy, or a carefully evaluated sensitivity, a gluten-free diet is not generally healthier. [E1,E3,E5,E6]

Some people with IBS or suspected non-celiac sensitivity may feel better after changing their diet, but the evidence does not always separate gluten from other wheat components or broader food changes. [E1,E2]

A symptom response can matter without proving that gluten caused it. [E1,E2]

Going gluten-free may also narrow food choices and reduce whole-grain, fibre, or vitamin and mineral intake if replacements are not chosen carefully. [E3,E4,E5]

Before spending more or restricting more, start with the reason for the change. For general health, look at the quality and balance of your whole diet rather than the gluten-free label. [E3,E5]

When symptoms are the concern, it helps to distinguish celiac disease, wheat allergy, IBS, and possible non-celiac sensitivity rather than treating them as the same problem. [E1,E2,E3]

Removing gluten is not the same as improving the whole diet. [E3,E5]

💭REFLECTION PROMPT

Something to reflect on…

When you see “gluten-free,” what are you assuming it tells you: medically necessary, easier to digest, or simply healthier? And what would change if you judged the whole eating pattern instead of the label?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Does creatine actually help beyond the gym?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

International Food Information Council. (2026). 2025 IFIC Food & Health Survey. Survey fielded March 13–27, 2025; report published January 2026. https://ific.org/wp-content/uploads/2025-IFIC-Food-Health-Survey-Full-Report.pdf 🔓

H2

Grand View Research. (2026). Gluten-free products market. Grand View Research. 2025 market value; forecast period 2026–2033; report published and last updated June 2026. https://www.grandviewresearch.com/industry-analysis/gluten-free-products-market 🔒

H3

Beyond Celiac. (2023). The Persisting Myths About Celiac Disease: Americans’ Attitudes and Understanding Are Falling Short. Beyond Celiac. Survey conducted April 11–13, 2023; report published June 2023. https://www.beyondceliac.org/wp-content/uploads/2023/06/2023-Beyond-Celiac-Harris-Report-06.23-1.pdf 🔓

E1

Biesiekierski, J. R., Jonkers, D., Ciacci, C., & Aziz, I. (2025). Non-coeliac gluten sensitivity. The Lancet, 406(10518), 2494–2508. https://doi.org/10.1016/S0140-6736(25)01533-8 🔓

E2

Dionne, J., Ford, A. C., Yuan, Y., Chey, W. D., Lacy, B. E., Saito, Y. A., Quigley, E. M. M., & Moayyedi, P. (2018). A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. American Journal of Gastroenterology, 113(9), 1290–1300. https://doi.org/10.1038/s41395-018-0195-4 🔒

E3

Niland, B., & Cash, B. D. (2018). Health Benefits and Adverse Effects of a Gluten-Free Diet in Non–Celiac Disease Patients. Gastroenterology & Hepatology, 14(2), 82–91. https://pubmed.ncbi.nlm.nih.gov/29606920/ 🔓

E4

Russell, L. A., Alliston, P., Armstrong, D., Verdu, E. F., Moayyedi, P., & Pinto-Sanchez, M. I. (2025). Micronutrient Deficiencies Associated with a Gluten-Free Diet in Patients with Celiac Disease and Non-Celiac Gluten or Wheat Sensitivity: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 14(14), 4848. https://doi.org/10.3390/jcm14144848 🔓

E5

Lebwohl, B., Cao, Y., Zong, G., Hu, F. B., Green, P. H. R., Neugut, A. I., Rimm, E. B., Sampson, L., Dougherty, L. W., Giovannucci, E., Willett, W. C., Sun, Q., & Chan, A. T. (2017). Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ, 357, j1892. https://doi.org/10.1136/bmj.j1892 🔓

E6

Schmucker, C., Eisele-Metzger, A., Meerpohl, J. J., Lehane, C., Kuellenberg de Gaudry, D., Lohner, S., & Schwingshackl, L. (2022). Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, 2022(2), CD013556. https://doi.org/10.1002/14651858.CD013556.pub2 🔓

🎧 Prefer to listen?
Listen to Is a Gluten-Free Diet Healthier Without Celiac Disease? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at anti-aging skincare — not every anti-aging claim, but the ones that often get blurred together on labels: retinol, hyaluronic acid, peptides, and collagen creams that can sound equally convincing.

You may be comparing products and trying to figure out which promise is actually worth paying for.

Because in anti-aging skincare, the label can sound specific while the claim stays vague.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

On TikTok, the hashtag #antiaging contained more than 660,000 videos with over 7 billion collective views, based on retrievals in late 2023 and early 2024 [H1].

The global anti-wrinkle products market was valued at over 14 billion U.S. dollars in 2025 and is projected to reach over 26 billion U.S. dollars by 2033 [H2].

So this is not just a beauty-product question [H1,H2].

It is a practical search question: what should be on the label, how long should a product be used, and which claims are doing more marketing work than evidence work? [H1,H2]

When a topic is this visible and this commercial, the product claim needs a receipt check [H1,H2].

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

For this episode, I’m focusing on over-the-counter anti-aging skincare products — the kinds of creams and serums people are comparing on store shelves.

The simplest way through anti-aging skincare is to start with the result being promised.

If the goal is to reduce the appearance of wrinkles, uneven texture, pigmentation, or skin changes from long-term sun exposure — often called photoaging — retinoids are the first ingredient category to understand [E1,E2,E3].

A broad review comparing topical treatments for facial photoaging included 23 randomized controlled trials — studies where people are assigned to different treatment groups — with over 3,900 participants [E1].

In that review, several retinoids improved visible signs such as fine wrinkles, coarse wrinkles, or hyperpigmentation, but no single retinoid came out as best for every outcome [E1].

Retinoids are a broader family of ingredients. Prescription tretinoin is the benchmark for photoaging, but it is stronger, more regulated, and can also be more irritating [E2,E3].

For store-shelf products, the retinoid words to look for are retinol or retinaldehyde, which is often called retinal [E3].

So if someone is asking whether over-the-counter retinol works, the answer is yes — it can help some visible signs. But it should not be treated as identical to prescription tretinoin [E2,E3].

So the practical translation for store-shelf products is simple: look for retinol or retinal, and judge results over weeks to months, not days [E1,E2,E3].

One important context point from Episode 27: sunscreen still matters because UV exposure is one of the main drivers of photoaging. Retinoids may help with some visible signs, while sun protection helps reduce ongoing UV damage.

Hyaluronic acid belongs in a different bucket [E5].

If the question is “does hyaluronic acid help wrinkles,” the more careful answer is that its clearest fit is hydration and smoother-looking skin, rather than treating it as a stand-alone wrinkle-repair ingredient [E5].

On a label, that usually means looking for hyaluronic acid or sodium hyaluronate when hydration is the goal [E5].

So hyaluronic acid may help skin look smoother through hydration, but compared with retinoids, the evidence is less direct for wrinkle or photoaging claims [E1,E2,E3,E5].

Peptide serums deserve careful wording because a label that says “peptides” does not tell you which peptide, dose, formula, or outcome was actually studied [E4].

This fits with the broader peptide message from Episode 23: some specific uses have modest, targeted benefits, but broad anti-aging promises often run ahead of the evidence.

In the skin-aging peptide review, there were 19 randomized controlled trials with over 1,300 participants [E4]. But only 2 were topical peptide studies [E4].
That means the review should not be heard as strong evidence that topical peptide serums work like retinoids [E1,E2,E3,E4]. The authors also noted major variation in peptide type, dose, formulation, and outcome measurement [E4].

So if a product just says “peptides,” that is not enough reason to choose it [E4].

For wrinkles, texture, pigmentation, or sun-related skin changes, look first to retinoids [E1,E2,E3,E4].

For hydration or smoother-looking skin, hyaluronic acid is the better fit [E5].

Peptides should be treated as an extra ingredient, not the main reason to buy. Unless a product can point to evidence for that exact formula, “peptides” on the label may not tell you very much [E4].

And then there is the collagen cream claim [E3,E4].
This is where the wording really matters.

Oral collagen supplements were covered separately in Episode 31, because they answer a different question.

For a topical cream, “contains collagen” is not the same as showing that the product rebuilds dermal collagen [E3,E4].

Dermal collagen means collagen in the deeper support layer of skin [E3].

A collagen cream claim may be about how the surface looks or feels, but that is different from evidence that a cream rebuilds collagen deeper in the skin [E3,E4].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that ingredient names feel like answers.

Retinol sounds familiar.
Hyaluronic acid sounds helpful.
Peptides sound scientific.
Collagen sounds intuitive.

And when a product gives us a word we recognize, it can feel easier to trust the promise.

The harder part is asking whether that word matches the result we want.

🧭THE TAKEAWAY

Your Evidence Edit moment.
So what’s the takeaway?

The most practical answer is to match the ingredient to the claim.
For claims about reducing visible signs of aging — wrinkles, texture, pigmentation, and sun-related skin changes — retinoids have the strongest evidence among the ingredient claims in this episode [E1,E2,E3]. But as we covered in Episode 27, sunscreen remains foundational because UV exposure is a major driver of photoaging.
Prescription tretinoin is stronger and better studied, while over-the-counter retinol or retinal are more accessible options that can still help some visible signs of photoaging [E2,E3].

What we do not know is whether every product with a familiar ingredient will give the same visible result [E1,E3,E4,E5].
Hyaluronic acid fits best with hydration and smoother-looking skin, not as the strongest wrinkle-repair claim [E1,E2,E3,E5].
Peptide serum evidence is limited, and a collagen cream claim should not be treated as proof of deeper dermal collagen rebuilding [E3,E4].

A practical product filter is to ask: what result do I want this product for?
If it is reducing visible signs of aging, look first for a retinoid; if it is hydration, hyaluronic acid makes more sense; if it is peptides or collagen cream, look much harder at the exact claim.
Then check whether the product names the ingredient, the intended outcome, and the time frame.

The clearer the claim, the easier it is to judge the evidence.

💭REFLECTION PROMPT

Something to reflect on…

Before buying an anti-aging product, try naming the result you actually want.

Is it fewer visible lines, smoother texture, more even pigmentation, better hydration, or a collagen cream claim?

Once the goal is clear, the label becomes easier to question: does this product give enough detail to match that promise?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Is a Gluten-Free Diet Healthier Without Celiac Disease?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Erdenebat, A., & Veloso da Silva, A. (2025). Digital ageism? Analyzing women’s depictions on TikTok through user-generated content under #aging and #antiaging. Mobile Media & Communication, 14(1). https://doi.org/10.1177/20501579251350900 🔓

H2

Grand View Research. (n.d.). Anti-wrinkle Products Market (2026 - 2033). Grand View Research. 2025 market size; 2026 estimate; 2033 projection; forecast period 2026–2033. https://www.grandviewresearch.com/industry-analysis/anti-wrinkle-products-market 🔒

E1

Lin, L., Chen, X., Liu, C., Wang, Q., Lian, W., Xu, X., Guo, Y., Zhong, H., Zhong, J., Zhao, N., Cheng, W., Shu, P., & Xu, Z. (2025). Comparative efficacy of topical interventions for facial photoaging: a network meta-analysis. Scientific Reports, 15, Article number: 26889. https://doi.org/10.1038/s41598-025-12597-0 🔓

E2

Siddiqui, Z., Zufall, A., Nash, M., Rao, D., Hirani, R., & Russo, M. (2024). Comparing Tretinoin to Other Topical Therapies in the Treatment of Skin Photoaging: A Systematic Review. American Journal of Clinical Dermatology, 25(6), 873–890. https://doi.org/10.1007/s40257-024-00893-w 🔒

E3

Griffiths, T. W., Watson, R. E. B., & Langton, A. K. (2023). Skin ageing and topical rejuvenation strategies. British Journal of Dermatology, 189(Supplement_1), i17–i23. https://doi.org/10.1093/bjd/ljad282 🔓

E4

Nukaly, H. Y., Halawani, I. R., Irtaza, H. M., Alturkistani, T., Serafi, M. R., Alhawsawi, W., Bogari, H. O., Ahmed, F. A., Alhaddad, Y., Shadid, A., Alharithy, R., & Jfri, A. (2026). Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 13, 1618306. https://doi.org/10.3389/fmed.2026.1618306 🔓

E5

Bravo, B., Correia, P., Gonçalves Junior, J. E., Sant’Anna, B., & Kerob, D. (2022). Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy, 35(12), e15903. https://doi.org/10.1111/dth.15903 🔓

🎧 Prefer to listen?
Listen to Are Which Anti-Aging Skincare Ingredients Actually Work? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

Thank you to this week’s guest, Rik Foote, Founder & CEO of HAEVN.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.
This episode looks at dating apps, swipe fatigue, matching algorithms, and compatibility claims — because the promise can sound simple, even when the decision feels personal.

For this episode, I’m focusing on apps designed to help people meet, date, match, or build romantic connection. I’m not covering paid attention platforms, AI companions, or services that sell emotional connection without the goal of meeting someone.

Maybe you are swiping, pausing, deleting the app, or wondering whether a more intentional platform would feel different.

Connection is already hard enough without trying to decode what an app can actually promise.

To bring a real-world product perspective into this conversation, I spoke with Rik Foote from HAEVN.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz around dating apps is not just that they help people meet. It is the bigger promise that smarter matching can make dating feel less frustrating.

And this is not a niche question. In a July 2022 Pew Research Center survey, three in ten U.S. adults said they had ever used a dating site or app, the same share reported in 2019 [H1].

There is also a large business behind the promise. One market report estimated the global online dating market at over 12 billion U.S. dollars in 2025, with projected growth to over 23 billion U.S. dollars by 2034 [H2].

But the experience can also be exhausting. In a 2024 survey of 1,000 U.S. adults who had used a dating app within the previous year, nearly eight in ten said they sometimes, often, or always felt emotionally, mentally, or physically exhausted by dating apps [H3]. The most common reasons included struggling to find a good connection, disappointment, rejection, repetitive conversations, and swiping itself [H3].

So the question is not just whether dating apps are popular. It is what they can reasonably do, what they have not proven, and where design choices may still matter.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The strongest evidence is not that dating apps can predict love. It is that they can expand access [E1]. A major psychological review found that online dating can help people find and contact potential partners beyond their usual social circles [E1]. That access can change who someone has the chance to meet [E1].

But the same review found much weaker evidence for the bigger promise: that compatibility algorithms can reliably predict long-term romantic outcomes [E1]. So the evidence supports dating apps as a way to meet more people [E1]. It does not strongly support the idea that an app can know, in advance, who will become the right partner [E1].

That distinction is important because dating app use is not one behaviour with one goal [E4]. One systematic review — a study that reviews available research on a topic — found that people use dating apps for different reasons, including connection, dating, sex, curiosity, entertainment, and validation [E4]. So asking whether dating apps “work” is too broad. Work for what? A date, a conversation, a relationship, a confidence boost, or a way to pass time? The answer depends on the goal [E4]. That also helps explain why swipe fatigue can mean different things for different people: struggling to find a good connection, disappointment, repetitive conversations, or simply a mismatch between what the person wants and what the app experience provides [H3,E4].

Wellbeing is part of the picture too. A 2026 systematic review and meta-analysis — a study that combines results across studies — found that dating app users, on average, reported worse psychological health and wellbeing than non-users, including anxiety, loneliness, and distress [E2]. But that does not mean dating apps caused those outcomes, or that every user is struggling [E2]. The more careful takeaway is that wellbeing should be part of the conversation about the app experience, especially when the experience can feel repetitive, emotionally loaded, or hard to step away from [E2].

Researchers have also studied “problematic online dating,” but the field does not use one clear definition [E3]. That matters because simply using an app often, or feeling tired of it, does not automatically make the behaviour problematic [E3]. Researchers are looking at patterns involving loss of control, distress, difficulty cutting back, or app use that begins to interfere with everyday life [E3]. The harder questions are not just how often someone opens the app, but why they are using it, whether they still feel in control, and what the experience is doing to their wellbeing [E3].

Safety also belongs in the evidence picture.

In 2023, the U.S. Federal Trade Commission received more than 64,000 reports of romance scams. Reported losses reached over 1 billion U.S. dollars, with a median reported loss of 2,000 dollars per person [H4]. Those figures are not limited to dating apps; romance scams can also begin through social media or other online contact [H4].

A systematic review found that scammers may create false identities, build trust and emotional connection over time, and then use that relationship for financial gain [E5]. Research on prevention, victim support, and platform responses is still developing [E5]. That is why safety, verification, privacy, reporting, and user control belong in the evaluation of a dating platform [H4,E5].

So the evidence does not reduce dating apps to good or bad. Access is better supported than algorithmic prediction [E1]. Wellbeing findings require careful, non-causal interpretation [E2]. Problematic online dating does not yet have one settled definition [E3]. Safety also belongs in the evaluation of the platform experience [H4,E5]. Newer app designs should be judged by the claims they make — and the evidence they can eventually show.

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Dating apps offer a sense of motion. You can open the app, make a choice, and feel like you are doing something.

But that motion may start to feel tiring when conversations feel repetitive, intentions feel unclear, or matches seem to go nowhere. That may help explain the appeal of a newer app promising fewer mismatches, clearer intentions, or a more thoughtful experience.

The promise is easy to understand: better inputs, better matches, better chances.

So I wanted to ask what this looks like from inside a dating app trying to do things differently.

🧭GUEST INSIGHTS AND TAKEAWAY

To explore how one newer platform is thinking about these issues, I spoke with Rik Foote from HAEVN.

So Rik, when someone comes to HAEVN already tired of the usual dating-app experience, what are they hoping will feel different?

[Rik: I think people are hoping dating feels intentional again. For many, it’s become a constant process of searching, evaluating, and wondering if they’re wasting their time. HAEVN starts by understanding what someone is actually looking for, then makes introductions based on that. It lets people spend less time managing dating, and more time living their lives.]

That distinction between dating and managing dating is useful.

You also use the language of compatibility. What does that mean inside HAEVN — and where do you draw the line between making a more informed introduction and predicting the outcome?

[Rik: Intent comes first. Before we ask whether two people are compatible, we ask whether or not they’re trying to build the same kind of relationship or not. Because if they’re not, compatibility is almost irrelevant. Once intent is aligned, we measure compatibility across the things that research and experience suggest matter over time. We don’t predict love, we don’t guarantee chemistry, we simply reduce uncertainty before we make introductions.]

So, in HAEVN’s framing, compatibility is a better-informed starting point, not a prediction about how the relationship will end.

The broader evidence supports expanded access more strongly than it supports claims that algorithms can predict long-term romantic outcomes [E1]. How does that fit with the way you describe what HAEVN can — and cannot — do?

[Rik: I actually agree with the research. We don’t believe anyone can reliably predict the outcome of a relationship. And that’s one of the key distinctions between HAEVN and platforms like eHarmony. We’re not trying to predict success, we’re trying to make better introductions. So if two people share the same relationship intent, and also demonstrate a high degree of compatibility, we think that makes a much better place to start. What happens after that is completely up to them.]

So the distinction you are making is between improving the introduction and predicting relationship success.

Safety is another place where the platform and the person both have a role. From your perspective, what responsibilities belong to the app, and what still has to remain with the user?

[Rik: I believe dating platforms in particular have a responsibility to create a trustworthy environment. That means verifying people are real, protecting their privacy, being transparent about how matching works, and giving members control over their information. But no platform can replace good judgment. Meeting someone will always involve human decision. And I think it’s our job to reduce as much unnecessary risk and uncertainty before that first conversation even happens.]

That balance — what HAEVN says it can improve and what still belongs to the person — is a useful place to land.

Rik, thank you for bringing the builder’s perspective into this conversation.

Your Evidence Edit moment.
So what’s the takeaway?

Dating apps can widen who you have the chance to meet [E1]. What they have not shown is that a compatibility algorithm can reliably predict who will build a strong relationship [E1].

That does not make every design choice irrelevant. An app can still try to reduce friction, clarify intentions, protect privacy, or change how introductions are made. Those are narrower promises than predicting love, and they should be judged by what the platform actually does.

Start with your own goal. Are you looking for a relationship, a date, a conversation, validation, entertainment, or simply a wider pool of people to meet? People use dating apps for different reasons, so asking whether an app “works” only makes sense once you define what “work” means for you [E4].

Then ask three questions: What is this app helping me do? What is it claiming to know? And what judgment still belongs to me?

It is also worth looking at how the platform handles verification, privacy, reporting, and control over personal information [H4,E5].

A better starting point can help; it cannot choose the relationship for you.

💭REFLECTION PROMPT

Something to reflect on…

When you hear a dating app promise better matches, which part of that promise matters most to you?

Is it access? Compatibility? Safety? Wellbeing? Less wasted time?

And what would help you feel clear enough to decide whether the app is worth your attention?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Which Anti-Aging Skincare Ingredients Actually Work?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Pew Research Center. (2022). Share of U.S. adults who have ever used a dating site or app. Pew Research Center. https://www.pewresearch.org/short-reads/2023/02/02/key-findings-about-online-dating-in-the-u-s/

H2

Fortune Business Insights. (2025). Global online dating market size. Fortune Business Insights. https://www.fortunebusinessinsights.com/online-dating-market-115542

H3

Prendergast, C. (2025, July 25). Forbes Health Survey: 78% Of All Users Report Dating App Burnout. Forbes Health. Data collected March 27–April 1, 2024. Online survey of 1,000 U.S. adults who had used a dating app within the previous year, commissioned by Forbes Health and conducted by OnePoll. https://www.forbes.com/health/dating/dating-app-fatigue/

H4

Fair, L. (2024, February 13). “Love Stinks” – when a scammer is involved. Federal Trade Commission. Date of statistic if provided: 2023. https://www.ftc.gov/business-guidance/blog/2024/02/love-stinks-when-scammer-involved

E1

Finkel, E. J., Eastwick, P. W., Karney, B. R., Reis, H. T., & Sprecher, S. (2012). Online Dating: A Critical Analysis From the Perspective of Psychological Science. Psychological Science in the Public Interest, 13(1), 3–66. https://doi.org/10.1177/1529100612436522 🔒

E2

Sharabi, L. L., Ou, L., Von Feldt, P. A., & Parsons, T. D. (2026). Dating app use, psychological health, and psychological well-being: A systematic review and quantitative meta-analysis. Computers in Human Behavior, 177, 108879. https://doi.org/10.1016/j.chb.2025.108879 🔒

E3

Thomas, M. F., Dörfler, S., Mittmann, G., & Steiner-Hofbauer, V. (2025). Problematic Online Dating: Systematic Review of Definitions, Correlates, and Study Designs. Journal of Medical Internet Research, 27, e72850. https://doi.org/10.2196/72850 🔓

E4

Castro, Á., & Barrada, J. R. (2020). Dating Apps and Their Sociodemographic and Psychosocial Correlates: A Systematic Review. International Journal of Environmental Research and Public Health, 17(18), 6500. https://doi.org/10.3390/ijerph17186500 🔓

E5

Bilz, A., Shepherd, L. A., & Johnson, G. I. (2023). Tainted Love: a Systematic Literature Review of Online Romance Scam Research. Interacting with Computers, 35(6), 773–788. https://doi.org/10.1093/iwc/iwad048 🔓

🎧 Prefer to listen?
Listen to Can Dating Apps Really Find You a Better Match? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at microplastics — tiny plastic particles that have been detected in the human body.

That can sound alarming. But detection is not the same as knowing what it means for your health.

The real question is this: when you hear that microplastics are in blood, tissue, or other samples, what should you actually take from that?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Microplastics are now part of a much bigger public conversation about exposure, testing, and health risk.

Part of the buzz comes from blood-testing studies showing microplastic particles in human blood. In one study, particles were detected in about nine out of ten participants, with an average of about four particles per millilitre of blood. [H1]

That kind of result helps explain why blood detection gets noticed. [H1]

There is also a growing market around finding and measuring these particles. The global microplastic detection market was valued at over 5 billion USD in 2025, and it is projected to grow to over 9 billion USD by 2034. [H2]

So the buzz is understandable. When a topic shows up in human blood testing and in a growing testing market, it is worth asking what those messages do — and do not — tell us. [H1,H2]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, microplastics have been detected in human samples, including blood, urine, stool, lung tissue, breast milk, semen, and the placenta. [E3,E4]

One review also reported microplastics in 8 of 12 human organ systems reviewed, including cardiovascular, digestive, respiratory, reproductive, and urinary systems. [E3]

So the detection question is real. Microplastics have been found in the human body. [E3,E4]

But detection raises other questions: do particles build up over time, how much leaves the body, and how long might particles stay? Current human evidence does not yet answer those questions clearly. [E1,E3,E4]

That leads to exposure: how might microplastics be getting into the body in the first place? Reviews describe several possible routes, including food and water, air and dust, and possible skin contact. [E4,E5]

One review, focused on exposure, concluded that indoor air, food, and water all contribute to intake, with indoor settings and what people ingest playing important roles. [E5]

The harder question is what detection means for health. A 2026 systematic review — a study that pulls together the available research on a topic — looked at human studies that measured microplastics or even smaller nanoplastics in the body and examined possible links with health markers or health outcomes across several body systems. [E1]

It reported links with inflammation and other health-related changes, but the studies used different methods and had limits that make cause and effect hard to prove. [E1]

A 2024 review concluded that microplastic exposure raises concern for digestive, reproductive, and respiratory health. But much of that evidence came from animal studies. Animal studies can help scientists explore possible biological effects, but they do not tell us exactly what happens in people. The review included only three human observational studies, meaning studies that can look for links but cannot prove cause and effect. [E2]

So the evidence supports concern and more research, but not simple claims that one test result can predict one person’s future health risk. [E1,E2,E3,E4,E5]

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Because microplastics can make ordinary choices feel less ordinary.

A water bottle, a takeout container, a food wrapper, a plastic cutting board — things that used to feel normal can suddenly feel questionable.

And because the particles are invisible, people are left trying to judge risk without being able to see the thing they are worried about.

That is where testing can feel appealing. A number seems like it might bring certainty.

But the harder question is not only, “Can we measure it?”

It is, “What does that measurement mean — and what can I reasonably do about it?”

🧭THE TAKEAWAY

Your Evidence Edit moment.
So what’s the takeaway?

Microplastics are detectable in humans, and possible health risks deserve attention, but personal risk is not settled by a single test. [E1,E2,E3,E4]

The evidence does not support dismissing the issue as imaginary, because human detection has been reported across tissues and fluids. [E3,E4]

It also does not support treating every headline, test, or product claim as a direct measure of personal danger. [E1,E3,E4]

Because exposure may come through food, water, air, and dust, it is understandable to want to reduce it. [E5] But current evidence cannot tell us how much difference specific household changes make to someone’s total exposure or health. [E1,E3]

Choosing to use less plastic, especially when the change is simple and low-cost, can still be a reasonable precaution. The important distinction is that this is a precautionary choice — not a proven way to prevent disease. [E1,E2]

So the goal is not perfect control. It is proportionate choices, better questions, and less fear-driven decision-making.

Detection matters, but meaning is the real receipt check. [E1,E3,E4]

💭REFLECTION PROMPT

Something to reflect on…

When you see a microplastics claim, what question are you being asked to answer: “Is it detectable?”, “Is it harmful?”, or “What can I reasonably do with this information?”

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Can Dating Apps Really Find You a Better Match?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Lee, D.-W., Jung, J., Park, S.-A., Lee, Y., Kim, J., Han, C., Kim, H.-C., Lee, J. H., & Hong, Y.-C. (2024). Microplastic particles in human blood and their association with coagulation markers. Scientific Reports, 14, 30419. https://doi.org/10.1038/s41598-024-81931-9

H2

Fortune Business Insights. (2026). Microplastic Detection Market Size, Share, and Industry Analysis By Type (Polyethylene, Polystyrene, Polypropylene, PTFE, and Others), By Size (<1 Mm, 1-3 Mm, and 3-5 Mm), By Medium (Air, Water, and Soil), By Technology (FTIR Spectroscopy, Micro-Raman Spectroscopy, Pyrolysis- Gas Chromatography-Mass Spectroscopy (Py-GC-MS), Liquid Chromatography (LC) With Mass Spectroscopy (MS), Flow Cytometry, Scanning Electron Microscopy (Sem), and Others), By End-use (Water Treatment, Packaging, Cosmetics, Food and Beverage, Textiles, and Others), and Regional Forecast, 2026-2034. Fortune Business Insights. Last updated: July 27, 2026. Study period: 2021-2034. Base year: 2025. Historical data: 2021-2024. https://www.fortunebusinessinsights.com/microplastic-detection-market-111878 🔒

E1

Tran, H. A. A., Ng, J. J., Tang, D. H., Yong, C. T., & Ho, A. F. W. (2026). Health impacts of micro- and nanoplastics in humans: systematic review of in vivo evidence. Environmental Health, 25, 26. https://doi.org/10.1186/s12940-026-01282-y 🔓

E2

Chartres, N., Cooper, C. B., Bland, G., Pelch, K. E., Gandhi, S. A., BakenRa, A., & Woodruff, T. J. (2024). Effects of Microplastic Exposure on Human Digestive, Reproductive, and Respiratory Health: A Rapid Systematic Review. Environmental Science & Technology, 58(52), 22843–22864. https://doi.org/10.1021/acs.est.3c09524 🔓

E3

Roslan, N. S., Lee, Y. Y., Ibrahim, Y. S., Anuar, S. T., Ku Yusof, K. M. K., Lai, L. A., & Brentnall, T. (2024). Detection of microplastics in human tissues and organs: A scoping review. Journal of Global Health, 14, 04179. https://doi.org/10.7189/jogh.14.04179 🔓

E4

Zuri, G., Karanasiou, A., & Lacorte, S. (2023). Human biomonitoring of microplastics and health implications: A review. Environmental Research, 237(Pt 1), 116966. https://doi.org/10.1016/j.envres.2023.116966 🔓

E5

Zuri, G., Karanasiou, A., & Lacorte, S. (2023). Microplastics: Human exposure assessment through air, water, and food. Environment International, 179, 108150. https://doi.org/10.1016/j.envint.2023.108150 🔓

🎧 Prefer to listen?
Listen to Are Microplastics in Your Body Harmful? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at natural health products and dietary supplements — from everyday vitamins to herbal products and concentrated extracts.

Maybe it is something you take every day, something you are thinking about trying, or something someone recommended.

Natural can make a product feel easier to trust. But does natural tell us enough to trust the claim?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz around natural health products is not just one claim. It can show up as a multivitamin for prevention, an herbal product for wellness, or a capsule that sounds more reassuring because the ingredient is familiar.

And this is not a small corner of health culture. In the United States, over 60% of adults age 20 and older used at least one dietary supplement in the past 30 days during August 2021 to August 2023 — about 6 out of 10 adults [H1].

The market is large too. One market analysis valued the global dietary supplements market at over 200 billion USD in 2025, with projected growth to over 430 billion USD by 2033 [H2].

So the public-facing question is practical. When a product is common, easy to buy, and surrounded by confident claims, people need a better filter than “natural” or “popular” [H1,H2].

When something is widely used and heavily marketed, it is worth asking what those messages leave out [H1,H2].

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, benefit depends on the product and the claim. Natural health products are not all the same. A vitamin, a mineral, an herb, and a concentrated extract can raise different evidence and safety questions [E1,E2,E3,E4,E5].

For vitamins and minerals used for primary prevention — trying to prevent disease before it starts — an updated systematic review examined prevention of cardiovascular disease and cancer [E1]. A systematic review is a study that reviews available research on a topic [E1].

The review found little or no benefit for preventing cancer, cardiovascular disease, or death for most vitamin and mineral supplements in healthy adults without known nutritional deficiencies [E1]. One example is multivitamins. The review found a small benefit for cancer incidence, but that finding sat within a broader picture of little or no benefit for preventing cancer, cardiovascular disease, or death overall [E1].

Another example goes the other way. Beta carotene was linked with increased lung cancer risk and other harmful outcomes in people at high risk of lung cancer [E1]. So a supplement can sound preventive and still raise a harm question in a specific group [E1].

Second, “natural” does not necessarily mean gentler. A natural source does not mean a product is harmless [E2,E3,E4]. Some supplements have been linked with health problems, and some can interact with medicines [E2,E3,E4].

Safety cannot be assumed just because something is sold without a prescription. One study estimated about 23,000 emergency department visits each year in the United States were related to dietary supplement adverse events [E2]. An adverse event is the formal term for a side effect or health problem reported after using a product [E2].

The examples matter. Emergency visits commonly involved heart-related symptoms from weight-loss or energy products in younger adults, and swallowing problems linked mostly with vitamin or mineral supplements in older adults [E2].

Green tea extract is a useful example. Guidance from the American Association for the Study of Liver Diseases includes green tea extract among herbal and dietary supplements associated with liver injury reports [E3].

Third, interactions matter. Herb–drug interactions — when an herb affects a medicine — have been evaluated across systematic reviews [E4].

St. John’s wort, an herbal product some people use for mood, is one example where serious interactions have been noted [E4]. Ginkgo and ginseng are other examples where interaction concerns have been reported, especially around medicines that affect bleeding, such as antiplatelet drugs or anticoagulants — medicines that reduce blood clotting [E4].

So the practical question is not only “does this work?” It is also “could this change how another medicine works?” [E4].

Online information can make supplement decisions harder. Online nutrition information can have quality and accuracy problems, and social media misinformation has been studied across topics including vaccines, drugs, diets, diseases, and medical treatments [E6,E7].

For supplement decisions, that can mean people are sorting through nutrition content and social media messages that vary in quality, accuracy, and certainty [E6,E7].

So the evidence reframes the question. It is not “natural health products: good or bad?” It is “what is the product, what is the claim, what is the evidence, and what safety question does it raise?” [E1,E2,E3,E4,E5,E6,E7].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that a supplement feels like something you can do right now. A bottle labeled for sleep, energy, or daily wellness can feel more concrete than uncertainty.

The message can also feel gentler. A familiar plant, vitamin, or mineral can make a product feel safer, simpler, or easier to trust.

And repetition matters emotionally. When the same claim shows up in a feed, a store, and a confident recommendation, it can start to feel sensible.

That is why this topic can feel confusing. The choice looks simple from the outside, but the better question takes more work.

🧭THE TAKEAWAY

Your Evidence Edit moment.
So what’s the takeaway?

Natural health products are not automatically worth it, and they are not automatically safe. “Natural” is not enough information on its own; the answer depends on the product, the claim, and the safety context [E1,E2,E3,E4,E5].

A broad prevention claim is different from a specific product claim, and a familiar ingredient can still raise safety questions in some supplement contexts [E1,E3,E4].

Before trusting a product because it sounds natural, ask three questions: what exactly is it claiming, what evidence matches that claim, and what safety or interaction issue needs checking [E1,E2,E3,E4,E5,E6,E7]?

Natural is not the decision. The claim is.

💭REFLECTION PROMPT

Something to reflect on…

When you hear a supplement claim, what detail do you notice first?

Is it the word natural?
The ingredient name?
The promise on the label?
The person recommending it?
The feeling that it seems harmless?

And what would change if the first question became: “What exact claim is this product making?”

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Microplastics in Your Body Harmful?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Stierman, B., Couch, C. A., Gahche, J. J., & Mishra, S. (2026). Dietary supplement use: United States, August 2021–August 2023. NCHS Data Brief, 561, 1–11. Data period: United States, August 2021–August 2023. https://www.cdc.gov/nchs/products/databriefs/db561.htm

H2
Grand View Research. (2025). Dietary Supplements Market (2026 - 2033): Size, Share & Trends Analysis Report By Ingredients (Vitamin, Botanicals, Minerals, Proteins & Amino Acids), By Type, By Form, By Application, By End-user, By Distribution Channel, By Region, And Segment Forecasts. Grand View Research. Date of statistic if provided: 2025. https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market-report

E1
O’Connor, E. A., Evans, C. V., Ivlev, I., Rushkin, M. C., Thomas, R. G., Martin, A., & Lin, J. S. (2022). Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 327(23), 2334–2347. https://doi.org/10.1001/jama.2021.15650 🔓

E2
Geller, A. I., Shehab, N., Weidle, N. J., Lovegrove, M. C., Wolpert, B. J., Timbo, B. B., Mozersky, R. P., & Budnitz, D. S. (2015). Emergency Department Visits for Adverse Events Related to Dietary Supplements. The New England Journal of Medicine, 373(16), 1531–1540. https://doi.org/10.1056/NEJMsa1504267 🔓

E3
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023). AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology, 77(3), 1036–1065. https://doi.org/10.1002/hep.32689 🔓

E4
Posadzki, P., Watson, L. K., & Ernst, E. (2013). Herb–drug interactions: an overview of systematic reviews. British Journal of Clinical Pharmacology, 75(3), 603–618. https://doi.org/10.1111/j.1365-2125.2012.04350.x 🔓

E5
Kongkaew, C., Phan, D. T. A., Janusorn, P., & Mongkhon, P. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance, 10, e63808. https://doi.org/10.2196/63808 🔓

E6
Denniss, E., Lindberg, R., & McNaughton, S. A. (2023). Quality and accuracy of online nutrition-related information: a systematic review of content analysis studies. Public Health Nutrition, 26(7), 1345–1357. https://doi.org/10.1017/S1368980023000873 🔓

E7
Suarez-Lledo, V., & Alvarez-Galvez, J. (2021). Prevalence of Health Misinformation on Social Media: Systematic Review. Journal of Medical Internet Research, 23(1), e17187. https://doi.org/10.2196/17187 🔓

🎧 Prefer to listen?
Listen to Are Natural Health Products Safe and Effective? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at oral collagen supplements for skin, joints, and aging — because after Episode 23 on peptides, collagen stood out as the practical over-the-counter peptide question with modest, targeted benefits worth examining more closely.

Let’s do this together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz is that oral collagen can support skin, joints, recovery, and aging.
One market report says more than 60 million consumers globally incorporate collagen supplements into daily routines [H1].

Another report valued the collagen supplements market at over 3 billion U.S. dollars in 2025, with estimates rising to close to 6 billion by 2031 [H2].

So this is not a fringe question [H1,H2].

The practical question is: what can I realistically expect if one product may promise skin benefits, joint health, post-exercise recovery, and aging support? [H1,H2]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.
For skin, the evidence is cautiously positive, but not transformational.

Reviews of randomized trials — studies that compare people taking collagen with people taking a look-alike product without active collagen — have found that oral collagen can improve measured skin hydration and elasticity [E1,E2,E5].

Some reviews also found improvement in wrinkle measures when results from several trials were combined [E1,E2]. But a 2025 review was more cautious when it looked only at better-designed studies, or studies that were not funded by pharmaceutical companies [E1].

Most of the skin evidence studied hydrolyzed collagen, also called collagen peptides [E2]. The studies do not point to one best dose. They used doses ranging roughly from 0.6 grams to 12 grams per day [E2].

For someone comparing products, that means a daily dose in the few-grams-to-about-10-grams range is easier to compare with the skin evidence than a vague “beauty collagen” claim [E2].

And for skin, daily use for about 8 to 12 weeks is a more realistic timeframe before judging whether the benefit feels worth it [E2].

Hydration, elasticity, and wrinkle measures are real skin outcomes, but they are often measured with instruments — not by whether someone sees noticeable change in the mirror [E2].

So for skin, collagen may help with measured changes like hydration and elasticity, but the practical question is whether that kind of change matches the cost and expectation [E1,E2,E5].

For knee osteoarthritis, the evidence is more specific than a general joint-health claim.
The trials included people with knee osteoarthritis and measured pain using rating scales, like asking people how much their knee hurt [E3].
The meta-analysis found greater pain relief with collagen peptides than placebo, but all included studies were judged at high risk of bias [E3].
So if you are buying collagen for joints, the evidence lines up better with osteoarthritis symptom relief than with broad claims about joint support, cartilage repair, or prevention [E3,E5].

For training, collagen looks most relevant as an add-on to exercise.
A systematic review with meta-analysis found benefits from collagen peptides plus regular training for fat-free mass, tendon morphology, muscle architecture, maximal strength, and 48-hour reactive-strength recovery [E4].
Fat-free mass means body mass that is not fat.
The certainty ranged from moderate for body composition to low or very low for several other outcomes [E4].
The authors’ practical rationale was 15 grams of collagen peptides daily for at least 8 weeks, alongside training at least twice weekly — such as resistance training, or body-weight exercise combined with running [E4].

So this is not a shortcut.
It is a possible training-support tool, with modest and specific expectations [E4].

Across the evidence, the pattern is clear: collagen supplements may offer some benefits, but the strongest claims are specific [E1,E2,E3,E4,E5].

Skin hydration is not the same as looking younger.
Knee osteoarthritis pain is not the same as general joint health.
Training support is not the same as broad anti-aging [E1,E2,E3,E4,E5].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Part of the appeal may be that collagen feels like a low-friction choice.
It can feel easy to add and easy to understand.
The promise can land because it offers a small action with the hope of a visible or physical payoff.
The tension is not only what the product says.
It is what we start to expect from it.

🧭THE TAKEAWAY

Your Evidence Edit moment.

So what’s the takeaway?

Collagen is not automatically a bad buy, but it is best understood as a specific-outcome supplement, not a broad anti-aging solution [E1,E2,E3,E4,E5].

What holds up is a modest, cautiously positive signal for skin hydration and elasticity, a narrower signal for osteoarthritis symptom relief, and a training-linked signal when collagen peptides are paired with regular exercise [E1,E2,E3,E4,E5].

What we do not know is whether every product, dose, source, routine, or person will get the same result [E1,E2,E3,E4,E5].

A reasonable shelf test is to ask: what outcome am I buying this for, and does the label make the form, dose, and timeframe easy to compare with the evidence? [E1,E2,E3,E4,E5]

If the goal is simply to “support aging,” the promise is too broad to know what outcome you are buying — or whether the product is likely to give you the result you want [E1,E2,E3,E4,E5].

💭REFLECTION PROMPT

Something to reflect on…

When you see a collagen claim, what change are you actually expecting?
Is the product promising a specific outcome, or a general feeling of aging better?

And does that expectation match what you would consider worth your time, money, attention, or concern?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Natural Health Products Safe and Effective?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Fortune Business Insights. (2026, June 01). Collagen Supplements Market Size, Share & Industry Analysis, By Source (Bovine, Marine, Porcine, Poultry, and Others), By Function (Skin Health, Joint & Bone Health, Hair & Nail Health, Sports Nutrition, General Wellness, Gut Health, and Others), By Form (Powder, Capsules/Tablets, Liquid, Gummies, Softgels, and Others), By Collagen Type (Type I, Type II, Type III, Type IV & V, and Multi-collagen Blends), By Distribution Channel (Supermarkets/Hypermarkets, Pharmacies & Drug Stores, Specialty Stores, Online Retail, and Others), and Regional Forecast, 2026-2034. Fortune Business Insights. Last Updated: June 01, 2026. https://www.fortunebusinessinsights.com/collagen-supplements-market-106539

H2
Mordor Intelligence. (2026). Collagen Supplements Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031). Mordor Intelligence. Date of statistic if provided: 2025; 2026; forecast period 2026–2031. https://www.mordorintelligence.com/industry-reports/collagen-supplements-market

E1
Myung, S.-K., & Park, Y. (2025). Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Medicine, 138(9), 1264–1277. https://doi.org/10.1016/j.amjmed.2025.04.034 🔒

E2
Pu, S.-Y., Huang, Y.-L., Pu, C.-M., Kang, Y.-N., Hoang, K. D., Chen, K.-H., & Chen, C. (2023). Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients, 15(9), 2080. https://doi.org/10.3390/nu15092080 🔓

E3
Lin, C.-R., Tsai, S. H. L., Huang, K.-Y., Tsai, P.-A., Chou, H., & Chang, S.-H. (2023). Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research, 18(1), 694. https://doi.org/10.1186/s13018-023-04182-w 🔓

E4
Bischof, K., Moitzi, A. M., Stafilidis, S., & König, D. (2024). Impact of Collagen Peptide Supplementation in Combination with Long-Term Physical Training on Strength, Musculotendinous Remodeling, Functional Recovery, and Body Composition in Healthy Adults: A Systematic Review with Meta-analysis. Sports Medicine, 54(11), 2865–2888. https://doi.org/10.1007/s40279-024-02079-0 🔓

E5
Ravindran, R., Pizzol, D., López-Gil, J. F., Rahmati, M., Boyer, L., Fond, G., Butler, L., Stellato, A., Gawronska, J., Barnett, Y., Soysal, P., Eren, R., Onal, B., Yon, D. K., & Smith, L. (2026). Collagen Supplementation for Skin and Musculoskeletal Health: An Umbrella Review of Meta-Analyses on Elasticity, Hydration, and Structural Outcomes. Aesthetic Surgery Journal Open Forum, 8, ojag018. https://doi.org/10.1093/asjof/ojag018 🔓

🎧 Prefer to listen?
Listen to Do Collagen Supplements Actually Work? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

Thank you to this week’s guest, Dr. Adrian Wagg, Professor of Medicine, University of Alberta.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at bladder leakage, pelvic floor exercises, and treatment options — because the message can swing between “it’s normal, live with it” and “try this fix.”

Maybe leakage is affecting exercise, sleep, travel, confidence, or daily routines.

That can leave people unsure whether to ignore it, search for answers, or ask for help.

Mixed messages can waste time, money, attention, and concern when a private health question gets reduced to one-size-fits-all advice.

To bring a clinical perspective into this conversation, I spoke with Dr. Adrian Wagg, an internationally recognized incontinence expert from the University of Alberta, whose work includes bladder health and incontinence in aging.

Full disclosure: Dr. Wagg is also my husband.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Urinary incontinence means leaking urine when you do not mean to [E1].
The online question is not just, “Is this common?”
It is, “Is this something I just have to live with?”
That question matters because urinary incontinence is common [H1].

One large U.S. survey analysis focused on women aged 20 and older found that 63% reported urinary incontinence, or about 6 out of 10 women [H1].
That represented almost 80 million U.S. women [H1].

The cost is also substantial [H2].
Across EU countries, the estimated 2023 economic burden was almost €70 billion [H2].
That analysis included both males and females, while finding that females carried about four times the burden of males [H2].

So the buzz is understandable [H1,H2].
When something is common, costly, private, and surrounded by simple messages, it is worth asking what those messages leave out [H1,H2].

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The evidence points in two directions: urinary incontinence is common in women [H1], and treatment options exist [E1,E2,E4,E5].
A lot of the evidence we’re looking at here focuses on women, especially pelvic floor muscle training and stress leakage [H1,E1,E2,E3,E5].

A Cochrane overview found a wide evidence base for conservative treatment of urinary incontinence in women [E1].
Conservative treatment means non-surgical treatment [E1].
Pelvic floor muscle training is one of the best-supported conservative options [E1,E2].
Pelvic floor muscle training means exercises for the muscles that help support bladder control [E2].
A Cochrane review comparing pelvic floor muscle training with no treatment or inactive control treatments found that it can cure or improve symptoms in women with stress urinary incontinence and other types of urinary incontinence [E2].
That gives pelvic floor exercises real evidence weight, not just wellness buzz [E1,E2].
But pelvic floor exercises are not the whole story [E1,E3,E4,E5].
A 2024 Cochrane review compared different ways of doing pelvic floor muscle training [E3].
That matters because the evidence is not only about whether pelvic floor training can help, but also about how it is delivered and supported [E3].

The type of leakage also matters [E4,E5].
Stress urinary incontinence means leaking with pressure or exertion, such as movement, coughing, or physical activity [E5].
Overactive bladder is a different symptom pattern, linked to urgency, frequency, and sometimes urgency leakage [E4].

So the practical answer is not “just do Kegels” and not “nothing can be done” [E1,E2,E4,E5].
The better answer is: identify the leakage pattern, then match the treatment discussion to that pattern [E4,E5].

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Because both messages offer a kind of relief.
“It’s normal, live with it” can make leakage feel less alarming.
“Try this fix” can make it feel solvable without an awkward conversation.

One message says leakage is just part of pregnancy, exercise, menopause, aging, or having a body.

Another says one exercise routine can fix everything.

That combination can be powerful when something feels private, inconvenient, or easy to minimize.

The tension is that both messages can sound useful while still leaving people unsure what applies to them.

That is why this topic sits between everyday reassurance, online searching, and one-size-fits-all advice.

So I wanted to ask what this looks like in real clinical life.

🧭 GUEST INSIGHTS AND THE TAKEAWAY

To explore that, I spoke with Dr. Wagg.

Dr. Wagg, when people ask whether bladder leakage is something they just have to live with, what do you wish more people understood?
[Dr. Wagg: Many people believe that bladder leaks are a normal part of being a woman or getting older. Because of this, some people “just live with it.” They may buy pads, avoid going out, plan their day around bathrooms, or change their lifestyle in ways that are frustrating or inconvenient. But leaking urine is not something people should simply accept. It is common, but it is not normal. Getting advice early can help.]

Bladder leakage is often talked about as part of aging, but it can happen for different reasons. What is helpful — and what is unhelpful — about the aging message?
[Dr. Wagg: In older adults, bladder leaks are often not caused by aging. They may be linked to other health problems, such as heart disease, constipation, Parkinson’s disease, memory problems, or trouble getting around. Some medicines can also make bladder leaks worse. For this reason, it is usually better to look for the cause rather than saying, “It’s just aging.”]

A lot of online advice jumps straight to pelvic floor exercises. When are pelvic floor exercises useful, and when is that message too simple?
[Dr. Wagg: Pelvic floor muscle exercises can help many people. These exercises can help support the bladder in people with stress incontinence. They can also help people with urgency incontinence by making it easier to hold urine for longer. People usually get the best results when they are taught how to do the exercises properly and have follow-up support. However, pelvic floor exercises are only one part of treatment. They can take at least four months to make a clear difference. They also work best when combined with other treatments that address the bladder problem and any other health issues that may be making the leaking worse.]

The evidence separates stress urinary incontinence from overactive bladder symptoms. In plain language, how should people think about that difference?
[Dr. Wagg: There are different types of bladder leakage. Stress incontinence happens when urine leaks during physical pressure or movement. This might happen with coughing, laughing, sneezing, lifting, or exercise. It is more common in women, and it can also happen in men after prostate surgery. Overactive bladder is different. It causes a sudden, strong need to pass urine that is hard to put off. This is called urgency. Sometimes people leak urine before they reach the toilet. These types of bladder problems are treated in different ways. That is why it is important to understand what is causing the leakage before choosing a treatment.]

And if someone has been quietly putting up with leakage for months or years, what would you want their next step to be?
[Dr. Wagg: People should feel able to speak up and ask for help. A family doctor, nurse, physiotherapist, or other health care provider can give advice. Online symptom checkers or self-help questionnaires may also help people prepare for a conversation with their health care provider. Bladder leakage is still a topic many people feel embarrassed to talk about. But it is a health problem, and help is available. There are many things that can be done to improve symptoms and make life better.]

Thank you, Dr. Wagg — and yes, full disclosure again, I do also get to ask him these questions at home.

Your Evidence Edit moment.
So what’s the takeaway?

Urinary leakage is common, and the evidence supports treating it as a health issue with options, not as something people simply have to accept [H1,E1,E2,E4,E5].
Pelvic floor muscle training is one evidence-supported option, particularly in women and as part of conservative treatment [E1,E2].

Treatment can also include broader guideline-based discussions, depending on whether the pattern is stress urinary incontinence or overactive bladder [E4,E5].
What we don’t know from a simple social post is which pattern someone has, which approach fits best, or whether pelvic floor training alone is enough [E3,E4,E5].

A reasonable decision lens is to ask three questions: what kind of leakage is this, what options fit that pattern, and what are the tradeoffs [E4,E5].
That is where a real clinical conversation can help: identifying the leakage pattern, discussing the options, and weighing the tradeoffs [E4,E5].

Common is not inevitable; treatment is not one-size-fits-all.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a simple message about bladder leaks, does it help you understand the pattern?
Or does it make one answer sound like the whole story?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Do Collagen Supplements Actually Work?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Che, R., Simpson, R., Akbar, Z., Gilliam, K., Ahmed, A., & Farhan, B. (2026). Post-Pandemic Prevalence of Urinary Incontinence Among Women in the United States and Associated Risk Factors. International Urogynecology Journal, 37(3), 583–595. https://doi.org/10.1007/s00192-025-06280-1 🔒

H2

Bishop, C., Rodriguez-Cairoli, F., Hagens, A., Bermudez, M. A., Van Kerrebroeck, P., & Collen, S. (2025). Prevalence, Socioeconomic, and Environmental Costs of Urinary Incontinence in the European Union. European Urology, 88(2), 157–166. https://doi.org/10.1016/j.eururo.2025.05.025 🔓

E1

Todhunter-Brown, A., Hazelton, C., Campbell, P., Elders, A., Hagen, S., & McClurg, D. (2022). Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews, 2022(9), CD012337. https://doi.org/10.1002/14651858.CD012337.pub2 🔓

E2

Dumoulin, C., Cacciari, L. P., & Hay-Smith, E. J. C. (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews, 2018(10), CD005654. https://doi.org/10.1002/14651858.CD005654.pub4 🔓

E3

Hay-Smith, E. J. C., Starzec-Proserpio, M., Moller, B., Aldabe, D., Cacciari, L., Pitangui, A. C. R., Vesentini, G., Woodley, S. J., Dumoulin, C., Frawley, H. C., Jorge, C. H., Morin, M., Wallace, S. A., & Weatherall, M. (2024). Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews, 2024(12), CD009508. https://doi.org/10.1002/14651858.CD009508.pub2 🔓

E4
Nambiar, A. K., Arlandis, S., Bø, K., Cobussen-Boekhorst, H., Costantini, E., de Heide, M., Farag, F., Groen, J., Karavitakis, M., Lapitan, M. C. M., Omar, M. I., Peyronnet, B., Sakalis, V. I., Sihra, N., & Harding, C. K. (2022). European Association of Urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. European Urology, 82(1), 49–59. https://doi.org/10.1016/j.eururo.2022.01.045 🔓

E5

Carlson, K., Andrews, M., Bascom, A., Baverstock, R., Campeau, L., Dumoulin, C., Labossiere, J., Locke, J. A., Nadeau, G., & Welk, B. (2024). 2024 Canadian Urological Association guideline: Female stress urinary incontinence. Canadian Urological Association Journal, 18(4), 83–102. https://doi.org/10.5489/cuaj.8751 🔓

🎧 Prefer to listen?
Listen to Are Bladder Leaks Normal or Treatable? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

This episode looks at perimenopause symptoms, hormone testing, and clinical diagnosis — because when symptoms are real, changing, and hard to explain, the idea of a blood test can feel worth exploring.
If this is on your mind, it may be because you want something clearer than guesswork: a number, a label, or a reason for what is happening.
That makes it worth asking what a blood test can tell us — and what it cannot.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

The buzz is that a hormone test — usually a blood test — can tell you whether you’re in perimenopause.

Perimenopause is the transition toward menopause, and menopause is confirmed after 12 months without a period. [E1,E2,E6]

Symptoms can start before menopause is formally confirmed. During perimenopause, they may include hot flashes and night sweats, also called vasomotor symptoms. [E1,E5]

One pooled estimate found hot flashes in almost 60% of middle-aged women in perimenopause. [H1]

The workplace stakes are real too: a U.S. survey-based economic analysis estimated almost 2 billion dollars in annual loss from missed workdays due to menopause symptoms. [H2]

When symptoms show up at this scale and the costs are substantial, the wish for a clearer answer is understandable. [H1,H2]
That is where the simple blood-test promise comes in: one number that seems like it could explain what is happening.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The strongest pattern is practical: for many women in the usual midlife age range, perimenopause is identified from symptoms and menstrual cycle changes, not from routine hormone panels. [E1,E2,E3]

The European Society of Endocrinology guideline says routine hormone blood tests are not needed to diagnose or manage perimenopause or menopause in women older than 45. [E1]

NICE, the National Institute for Health and Care Excellence, is a UK health-guidance body. It also centers identification and management on clinical assessment, which means a health professional considers the person’s symptoms, age, and menstrual pattern. [E2]
Clinical assessment means using the health story and exam context. [E1,E2]

Hormone levels can fluctuate during this transition, so one result may not settle the question. [E1,E5,E6]

FSH, or follicle-stimulating hormone, is a hormone signal from the brain that helps regulate ovulation. [E1,E6]
FSH testing can be considered in women aged 40 to 45 with symptoms, and it is recommended when premature ovarian insufficiency is suspected under the age of 40. [E1,E2]

Premature ovarian insufficiency means ovaries slow earlier than expected. [E1,E2]
AMH, or anti-Müllerian hormone, is a marker linked with how many eggs remain in the ovaries. [E4]
A systematic review — a study that reviews available research — found AMH was associated with timing of menopause, yet AMH alone could not predict menopause age closely enough to give a clear personal timeline. [E4]
That same review found no evidence that AMH testing could replace the 12 months without a menstrual period used to formally diagnose menopause. [E4]

So the evidence does not support AMH as a simple yes-or-no test for menopause timing. [E4]

Reproductive aging is best seen as stages based on menstrual patterns, with hormones as supportive markers rather than giving the whole answer. [E6]

🧠WHY THIS BUZZ RESONATES

So why does this resonate?

Because real symptoms can be hard to explain.
A blood test can seem to offer something simpler: one number, one label, one reason.
That can feel especially appealing when symptoms are disruptive, scattered, or easy for other people to minimize.
The promise is not just information.
It is validation.
It can feel like a way to make an uncertain body experience visible, nameable, and easier to talk about.
That is why the hormone-testing message can land so strongly.

🧭THE TAKEAWAY

Your Evidence Edit moment.

So what’s the takeaway?

For typical midlife symptoms and changing periods, the strongest evidence supports clinical diagnosis over routine hormone testing. [E1,E2,E3]
In plain language, the health story often matters more than a blood test. [E1,E2,E6]

Hormone testing has a narrower role, especially around younger ages or possible premature ovarian insufficiency. [E1,E2]

AMH may relate to menopause timing across groups, but the evidence does not support using AMH alone to give one person a precise forecast of when menopause will happen. [E4]

It’s more reasonable to ask whether testing would change the next step in your care, or simply add another number to interpret. [E1,E2,E3]

It may be worth giving more attention to symptoms, cycle pattern, and a shared conversation about options. [E1,E2,E3]

Start with the pattern, ask what the test would change, and keep the person — not the lab number — at the center.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a claim that a hormone test can finally explain perimenopause, what would you want that test to change: your understanding, your care options, your peace of mind, or all three?

And if the result would not change the next step, what other evidence from your own pattern might deserve attention?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Bladder Leaks Normal or Treatable?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Fang, Y., Liu, F., Zhang, X., Chen, L., Liu, Y., Yang, L., Zheng, X., Liu, J., Li, K., & Li, Z. (2024). Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis. BMC Public Health, 24, 1767. https://doi.org/10.1186/s12889-024-19280-5 🔓

H2
Faubion, S. S., Enders, F., Hedges, M. S., Chaudhry, R., Kling, J. M., Shufelt, C. L., Saadedine, M., Mara, K., Griffin, J. M., & Kapoor, E. (2023). Impact of Menopause Symptoms on Women in the Workplace. Mayo Clinic Proceedings, 98(6), 833–845. https://doi.org/10.1016/j.mayocp.2023.02.025 🔒

E1
Lumsden, M. A., Dekkers, O. M., Faubion, S. S., Hirschberg, A. L., Jayasena, C. N., Lambrinoudaki, I., Louwers, Y., Pinkerton, J. V., Sojat, A. S., & van Hulsteijn, L. (2025). European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause. European Journal of Endocrinology, 193(4), G49–G81. https://doi.org/10.1093/ejendo/lvaf206 🔓

E2
National Institute for Health and Care Excellence. (2026). Menopause: identification and management. NICE guideline, NG23. https://www.nice.org.uk/guidance/ng23 🔓

E3
British Menopause Society, Royal College of Obstetricians and Gynaecologists, Society for Endocrinology, College of Sexual and Reproductive Healthcare, Faculty of Pharmaceutical Medicine, & Royal Pharmaceutical Society. (2026). Menopause Practice Standards. British Menopause Society, 1–13. https://thebms.org.uk/wp-content/uploads/2026/05/NEW-BMS-Menopause-Practice-Standards-MAY2026-A.pdf 🔓

E4
Nelson, S. M., Davis, S. R., Kalantaridou, S., Lumsden, M. A., Panay, N., & Anderson, R. A. (2023). Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. Human Reproduction Update, 29(3), 327–346. https://doi.org/10.1093/humupd/dmac045 🔓

E5
Santoro, N., Roeca, C., Peters, B. A., & Neal-Perry, G. (2021). The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of Clinical Endocrinology & Metabolism, 106(1), 1–15. https://doi.org/10.1210/clinem/dgaa764 🔓

E6
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., Broekmans, F. J. M., STRAW + 10 Collaborative Group, & de Villiers, T. J. (2012). Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive Aging. The Journal of Clinical Endocrinology & Metabolism, 97(4), 1159–1168. https://doi.org/10.1210/jc.2011-3362 🔓

🎧 Prefer to listen?
Listen to Can a Blood Test Diagnose Perimenopause? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at mental health self-diagnosis, symptom interpretation, and how accurate online mental health information really is.
A lot of people are trying to understand difficult feelings, stress, attention, burnout, or anxiety in everyday life.
And mixed messages online can make people spend emotional energy trying to label normal experiences or interpret symptoms alone.
Sometimes certainty online feels easier than uncertainty in real life.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Spend a few minutes online and mental health language is everywhere.
ADHD, trauma, anxiety, autism, burnout, depression — the words show up in videos, captions, comments, and quizzes.

And for many people, this content is not just something to watch. It becomes a way to interpret themselves. [H1]

One 2025 survey reported that nearly one-third of respondents said they had self-diagnosed a mental health condition based on information they saw online. [H1]

At the same time, the business around digital mental health tools is growing quickly. [H2]
One market report estimated the global mental health apps market at about 7.5 billion U.S. dollars in 2024, with continued rapid growth projected through 2030. [H2]

That growth reflects something real.
People are looking for language, reassurance, and a way to make sense of experiences that can feel hard to explain.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A systematic review — a study that reviews available research on a topic — found that mental health and neurodivergence content on social media varies widely in quality and reliability. [E1]
The review also found examples of misinformation, oversimplified symptom descriptions, and content that sometimes blurred the line between education, identity, and diagnosis. [E1]

That does not mean all online mental health content is wrong.
Some tools and questionnaires can help identify people who may need further assessment. [E2][E3]

But most screening tools are designed for screening, not diagnosis. [E2][E3]
That distinction matters.

For example, the PHQ-9 — a common depression questionnaire — has been studied extensively as a screening tool for major depression. [E4]
And the GAD-7 — a common anxiety questionnaire — has been studied as a screening tool for anxiety disorders. [E5]

Screening means identifying people who might need more evaluation.
It does not mean confirming a diagnosis on its own. [E2][E3][E4][E5]

The evidence also shows that digital psychiatry tools vary in accuracy and validation. [E2]
Some appear promising in certain settings, while others have limited evidence or inconsistent performance. [E2]

And this brings us to another important part of the conversation: overdiagnosis.

Overdiagnosis means identifying a condition in ways that may not improve health or may label normal variation as disorder. [E6]

Researchers in mental health have raised concerns about how diagnostic boundaries can expand over time. [E6][E7]
Some symptoms can overlap with stress, grief, personality, sleep problems, life transitions, or normal emotional variation. [E6][E7]

And that context is often missing from short-form online content. [E1]

🧠WHY THIS BUZZ RESONATES

So why does this trend resonate?

Because mental health language can feel clarifying.
It can give people words for experiences that felt confusing or hard to explain.
And when someone has been struggling, a short video or symptom list can feel like a door opening.
There is relief in thinking,
“Oh — maybe this explains me.”
That does not mean the explanation is wrong.
But it also does not mean it is complete.

Sometimes, a label can help someone feel less alone or seek support.

But a label can also become a shortcut, especially when normal stress, grief, sleep loss, personality, burnout, and life transitions can overlap with mental health symptoms.

Online, that nuance can be hard to hold onto.

🧭THE TAKEAWAY

So what’s the takeaway?

The strongest evidence supports a careful distinction: online mental health content and screening tools can help people recognize possible symptoms, but they are not substitutes for full clinical assessment. [E1][E2][E3][E4][E5]
Some screening questionnaires can help identify people who may need further evaluation, while social media content varies greatly in quality and can oversimplify complex experiences. [E1][E2][E3][E4][E5]
The evidence also suggests that concerns about overdiagnosis and labeling normal emotional variation are legitimate parts of this discussion. [E6][E7]

It can feel difficult separating insight from identity online.

A useful next step is to treat online mental health content as a starting point for reflection — not the final answer. If a symptom is persistent, distressing, or affecting daily life, that is a good reason to seek a fuller assessment.

Your Evidence Edit moment:

Online mental health content can make your symptoms feel suddenly clear — but clarity is not the same as diagnosis. [E1][E2][E3]
A screening tool is designed to flag possible concerns, not confirm a diagnosis. [E2][E3][E4][E5]
The strongest evidence suggests some questionnaires can support early recognition, while social media content varies widely in quality and reliability. [E1][E2][E3][E4][E5]
Researchers also caution that expanding mental health labels too broadly may blur the line between disorder and normal human distress. [E6][E7]

A post can help something click — but it cannot see the full context of your life.

Some symptoms deserve attention, and some patterns need support. But understanding yourself and diagnosing yourself are not always the same process.

💭REFLECTION PROMPT

Something to reflect on…
When you hear mental health advice online, is it helping you understand your experience — or turning a complex feeling into a label too quickly?
And is it leaving room for context, uncertainty, and normal human variation?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Perimenopause symptoms, hormone testing, and clinical diagnosis

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

LifeStance Health. (2025, April 15). LifeStance Health. https://lifestance.com/insight/social-media-mental-health-impact-statistics-2025/

H2

Grand View Research. (2024). Grand View Research. https://www.grandviewresearch.com/industry-analysis/mental-health-apps-market-report

E1

Carter, A., Gracey, F., Moody, J., Ovens, A., & Chatburn, E. (2026). Quality, reliability and misinformation in mental health and neurodivergence content on social media: a systematic review. Journal of Social Media Research, 3(1), 30–47. https://doi.org/10.29329/jsomer.84 🔓

E2

Martin-Key, N. A., Spadaro, B., Funnell, E., Barker, E. J., Schei, T. S., Tomasik, J., & Bahn, S. (2022). The Current State and Validity of Digital Assessment Tools for Psychiatry: Systematic Review. JMIR Mental Health, 9(3), e32824. https://doi.org/10.2196/32824 🔓

E3

van Ballegooijen, W., Riper, H., Cuijpers, P., van Oppen, P., & Smit, J. H. (2016). Validation of online psychometric instruments for common mental health disorders: a systematic review. BMC Psychiatry, 16, 45. https://doi.org/10.1186/s12888-016-0735-7 🔓

E4

Negeri, Z. F., Levis, B., Sun, Y., He, C., Krishnan, A., Wu, Y., Bhandari, P. M., Neupane, D., Brehaut, E., Benedetti, A., Thombs, B. D., & Depression Screening Data (DEPRESSD) PHQ Group. (2021). Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ, 375, n2183. https://doi.org/10.1136/bmj.n2183 🔓

E5

Plummer, F., Manea, L. E., Trepel, D., & McMillan, D. (2016). Screening for Anxiety Disorders with the GAD-7 and GAD-2: A Systematic Review and Diagnostic Meta-Analysis. General Hospital Psychiatry, 39, 24–31. https://doi.org/10.1016/j.genhosppsych.2015.11.005 🔒

E6

Thombs, B. D., Turner, K. A., & Shrier, I. (2019). Defining and Evaluating Overdiagnosis in Mental Health: A Meta-Research Review. Psychotherapy and Psychosomatics, 88(4), 193–202. https://doi.org/10.1159/000501647 🔒

E7

Bolton, D. (2013). Overdiagnosis Problems in the DSM-IV and the New DSM-5: Can They Be Resolved by the Distress–Impairment Criterion? The Canadian Journal of Psychiatry, 58(11), 612–617. https://doi.org/10.1177/070674371305801106 🔒

🎧 Prefer to listen?
Listen to Should You Diagnose Your Mental Health Online? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at sunscreen use for sun protection, skin cancer prevention, vitamin D, and ingredient safety.

A lot of people are trying to balance sun protection with concerns about chemicals, ingredient safety, and vitamin D.
And mixed messaging online can leave people unsure what deserves attention.

Sometimes the loudest health debates hide the clearest answers.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Sunscreen has become one of those health topics that seems to trigger strong reactions online.

Some posts frame sunscreen as essential daily protection. Others raise concerns about chemical ingredients, cancer risk, or vitamin D. And some people question whether sunscreen prevents skin cancer at all.

At the same time, sunscreen use is inconsistent in real life. In one U.S. survey, about half of respondents said they mainly used sunscreen during large amounts of sun exposure, while only 13.5% reported daily use. Eleven percent said they never used sunscreen at all. [H1]

And this is also a major commercial market. The global sun care products market was estimated at more than 12 billion U.S. dollars in 2024. [H2]

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

Public-health guidance supports sunscreen as one part of skin cancer prevention, especially when combined with other sun-protection behaviours like seeking shade, wearing protective clothing, and limiting intense sun exposure. [E1]

The strongest evidence supports sunscreen for reducing damage from ultraviolet radiation — UV radiation, the part of sunlight linked to skin aging and skin cancer. [E1][E2]

A systematic review and meta-analysis — a study that pulls together available research and combines results when possible — examined sunscreen use and melanoma and non-melanoma skin cancer risk. The findings were mixed overall, with researchers noting that sunscreen studies are difficult to interpret because sunscreen use is inconsistent and people who use sunscreen may also differ in their sun exposure and baseline skin-cancer risk. [E3]

One review — a paper that summarizes and interprets research on a topic — concluded that the best available evidence supports sunscreen as effective for preventing skin cancer when used properly and consistently. [E2]

But there are important nuances.

Most people do not apply sunscreen as heavily or as consistently as it is tested in research settings. [E2]

And sunscreen use is not a permission slip for unlimited sun exposure. Public-health guidance presents sunscreen as one layer of protection, not the only one. [E1][E2]

Vitamin D is another major concern in online discussions.

Another review found that typical sunscreen use does not usually lead to vitamin D deficiency in real-world conditions. [E4]

That may sound surprising, but researchers note that most people apply sunscreen imperfectly and still receive some UV exposure. [E4]

Ingredient safety is where the conversation becomes more complicated.

A randomized clinical trial — a study where researchers assign people to specific products or routines — found that several sunscreen active ingredients could be detected in the bloodstream after people applied sunscreen at high-use levels. [E5]

But detecting absorption is not the same as proving harm. [E5][E6]

The FDA has said more safety data are needed for some sunscreen ingredients commonly used in the United States, while also emphasizing that sunscreen remains an important public-health tool. [E6]

So the evidence does not support the idea that all sunscreen is unsafe. But it also supports continued safety research and regulatory review of ingredients. [E5][E6]

🧠WHY THIS BUZZ RESONATES

So why does this trend resonate?

Skin cancer prevention feels personally relevant to many people. Concerns about chemicals and ingredient safety can also feel emotionally immediate.

There is also a familiar tension here: people hear that sunlight helps with vitamin D, but they also hear that they should protect their skin from UV damage.

And online conversations often flatten complicated risk discussions into all-or-nothing claims.

A little nuance changes the picture.

🧭THE TAKEAWAY

So what’s the takeaway?

The strongest guidance and review evidence supports sunscreen as part of effective sun protection and skin cancer prevention. [E1][E2]

The evidence also suggests that common concerns online are more nuanced than many headlines imply, especially around vitamin D and ingredient absorption. [E4][E5][E6]

It can feel hard choosing between competing health warnings online.

Practically, that means using sunscreen as one layer of protection — alongside shade, clothing, hats, and avoiding the strongest sun when you can. [E1][E2]

Your Evidence Edit moment:

Sunscreen helps prevent skin cancer, but that does not mean every sunscreen question is settled.
This conversation is really about balancing proven protection against UV damage with ongoing questions about ingredient safety and regulation.
The strongest guidance and review evidence supports sunscreen as an effective part of sun protection, while current evidence on ingredient absorption supports continued research rather than proof of harm. [E1][E2][E5][E6]
Protection and uncertainty can exist together without cancelling each other out.

Clearer context often makes health decisions feel less overwhelming.

💭REFLECTION PROMPT

Something to reflect on…
How much of your opinion about sunscreen comes from evidence — and how much comes from repetition, headlines, or social media framing?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Should You Diagnose Your Mental Health Online?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Patlola, M., Shah, A.A., Stead, T., Mangal, R., & Ganti, L. (2023). Sunscreen use amongst US adults: a national survey. Arch Dermatol Res 315, 2137–2138. https://doi.org/10.1007/s00403-023-02603-8 🔒

H2

Grand View Research. (2024). Grand View Research. https://www.grandviewresearch.com/industry-analysis/sun-care-products-market-report

E1

US Preventive Services Task Force. (2018). Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 319(11), 1134–1142. https://doi.org/10.1001/jama.2018.1623 🔓

E2

Sander, M., Sander, M., Burbidge, T., & Beecker, J. (2020). The efficacy and safety of sunscreen use for the prevention of skin cancer. CMAJ, 192(50), E1802-E1808. https://doi.org/10.1503/cmaj.201085 🔓

E3

Saes da Silva, E., Tavares, R., da Silva Paulitsch, F., & Zhang, L. (2018). Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis. European journal of dermatology : EJD, 28(2), 186–201. https://doi.org/10.1684/ejd.2018.3251 🔒

E4

Passeron, T., Bouillon, R., Callender, V., Cestari, T., Diepgen, T. L., Green, A. C., van der Pols, J. C., Bernard, B. A., Ly, F., Bernerd, F., Marrot, L., Nielsen, M., Verschoore, M., Jablonski, N. G., & Young, A. R. (2019). Sunscreen photoprotection and vitamin D status. British Journal of Dermatology, 181(5), 916-931. https://doi.org/10.1111/bjd.17992 🔓

E5

Matta, M. K., Florian, J., Zusterzeel, R., Pilli, N. R., Patel, V., Volpe, D. A., Yang, Y., Oh, L., Bashaw, E., Zineh, I., Sanabria, C., Kemp, S., Godfrey, A., Adah, S., Coelho, S., Wang, J., Furlong, L.-A., Ganley, C., Michele, T., & Strauss, D. G. (2020). Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA, 323(3), 256-267. https://doi.org/10.1001/jama.2019.20747 🔓

E6

U.S. Food and Drug Administration. (2021; current FDA Q&A page). Questions and Answers: FDA posts deemed final order and proposed order for over-the-counter sunscreen. U.S. Food and Drug Administration. https://www.fda.gov/drugs/understanding-over-counter-medicines/questions-and-answers-fda-posts-deemed-final-order-and-proposed-order-over-counter-sunscreen 🔓

🎧 Prefer to listen?
Listen to Is Sunscreen Safe — And Does It Work? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today, we’re looking at ultra-processed foods and health — and the question people are really asking: are these foods seriously harmful, or is this just another food panic?

A simple label clue is this: if the ingredient list reads more like a formulation than a recipe, it may be ultra-processed. Think additives, flavour enhancers, colours, emulsifiers, sweeteners, or ingredients you would not normally cook with at home. Examples include soft drinks, packaged snacks, sweetened cereals, instant noodles, and many ready-to-heat meals.

The concern is clear. But the real question is what to do with that information in everyday life.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Ultra-processed foods are not a fringe part of modern eating. In the United States, among people aged 1 year and older, the average share of calories from ultra-processed foods was 55.0% during August 2021 to August 2023. [H1]
Even after recent decreases among youth and adults, that is still a little more than half of total calories. [H1]

There is also a large commercial story here: one market forecast estimated that the ultra processed food market size would increase by over USD 850 billion between 2024 and 2029. [H2]

So the buzz is not coming from nowhere. Ultra-processed foods sit in the middle of daily eating patterns, health research, and a very large market.

That is why the topic travels so easily online. It touches what people eat, what companies sell, and what health headlines amplify.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

The evidence supports taking the health concern seriously. Across major health reviews, higher exposure to ultra-processed foods is consistently associated with poorer health outcomes. [E1, E2]

That pattern also appears in prospective cohort studies, where researchers follow groups of people over time. Higher ultra-processed food consumption was associated with higher risk of diabetes, hypertension, obesity, and dyslipidemia — meaning unhealthy blood fat patterns such as high triglycerides or low HDL cholesterol. The authors found a consistent positive association, while also noting that risk estimates varied depending on how intake was measured. [E3]

The American Heart Association’s science advisory focuses on ultraprocessed foods and heart and metabolic health. Its key point is that higher consumption of ultraprocessed foods is associated with risks to heart and metabolic health, while better evidence is still needed on which foods, ingredients, and patterns matter most. [E4]

There is also evidence focused on all-cause mortality — meaning death from any cause during the study follow-up period. In that review, higher ultra-processed food consumption was associated with higher all-cause mortality risk. [E5]

So, when people ask, “Are ultra-processed foods really that bad?” the clearest evidence-based answer is: the concern is real. Higher intake is linked with worse health outcomes, including broad health outcomes, heart and metabolic health, and mortality risk. [E1, E4, E5]

The important nuance is about cause. Much of the evidence is observational, meaning it can show links between ultra-processed food intake and health outcomes, but it cannot prove that processing alone caused every outcome. [E2, E3, E5]

So the practical conclusion is not, “Ignore ultra-processed foods.” It is also not, “Fear every packaged food.” The better conclusion is to reduce ultra-processed foods as an overall pattern, especially when they become the default. [E1, E2, E4]

🧠WHY THIS BUZZ RESONATES

So why does this trend resonate?

Food is personal and shaped by real life. Ultra-processed foods show up in breakfast, snacks, school lunches, workdays, travel, tight budgets, busy evenings, and family routines.

People are not just asking, “What does the evidence say?” They are also asking, “What does this mean for the way I actually live?”

And that is where the online conversation can become unhelpful. One side can make the concern sound exaggerated. The other can make everyday eating feel like failure.

The evidence gives us a better way through: we can take the pattern seriously, without turning food into fear.

🧭THE TAKEAWAY

So what’s the takeaway?

The bottom line is clear: higher ultra-processed food exposure is linked with poorer health outcomes. [E1, E2] What is less certain is how much comes from the processing itself, the overall diet pattern, or other factors connected with food choices. [E2, E3, E5]

It makes sense to want clarity without food becoming fear.

Your Evidence Edit moment:

The evidence on ultra-processed foods is clearer than the online debate makes it sound. Higher intake is consistently linked with poorer health outcomes, including heart and metabolic health and mortality risk. [E1, E4, E5] Most of the evidence cannot prove processing alone is the cause, and some risk estimates vary depending on how intake is measured, but the pattern is consistent enough to take seriously. [E1, E2, E3, E5] The clearest answer is to reduce ultra-processed defaults, not fear every packaged food.

A practical place to start is not with a ban. It is to reduce how often ultra-processed foods become the default. That might mean swapping sweetened cereal for plain oats, soft drinks for water, packaged snack cakes for fruit and yogurt, or instant noodles for soup with vegetables, beans, eggs, or leftover chicken. The goal is not perfection. It is shifting the pattern over time.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a claim about ultra-processed foods, is it helping you understand the pattern — or pushing you toward fear, guilt, or certainty too quickly?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.

You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Is Sunscreen Safe — And Does It Work?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Williams, A. M., Couch, C. A., Emmerich, S. E., & Ogburn, D. F. (2025). Ultra-processed food consumption among youth and adults: United States, August 2021–August 2023. NCHS Data Brief, 536, 1–11. https://dx.doi.org/10.15620/cdc/174612

H2

Technavio. (2025, January). Technavio. https://www.technavio.com/report/ultra-processed-food-market-industry-analysis

E1

Lane, M. M., Gamage, E., Du, S., Ashtree, D. N., McGuinness, A. J., Gauci, S., Baker, P., Lawrence, M., Rebholz, C. M., Srour, B., Touvier, M., Jacka, F. N., O’Neil, A., Segasby, T., & Marx, W. (2024). Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ, 384, e077310. https://doi.org/10.1136/bmj-2023-077310 🔓

E2

Dai, S., Wellens, J., Yang, N., Li, D., Wang, J., Wang, L., Yuan, S., He, Y., Song, P., Munger, R., Potvin Kent, M., MacFarlane, A. J., Mullie, P., Duthie, S., Little, J., Theodoratou, E., & Li, X. (2024). Ultra-processed foods and human health: An umbrella review and updated meta-analyses of observational evidence. Clinical Nutrition, 43(6), 1386-1394. https://doi.org/10.1016/j.clnu.2024.04.016 🔓

E3

Vitale, M., Costabile, G., Testa, R., D’Abbronzo, G., Nettore, I. C., Macchia, P. E., & Giacco, R. (2024). Ultra-Processed Foods and Human Health: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Advances in Nutrition, 15(1), 100121. https://doi.org/10.1016/j.advnut.2023.09.009 🔓

E4

Vadiveloo, M. K., Gardner, C. D., Bleich, S. N., Khandpur, N., Lichtenstein, A. H., Otten, J. J., Rebholz, C. M., Singleton, C. R., Vos, M. B., & Wang, S. (2025). Ultraprocessed Foods and Their Association With Cardiometabolic Health: Evidence, Gaps, and Opportunities: A Science Advisory From the American Heart Association. Circulation, 152(12), e245-e263. https://doi.org/10.1161/CIR.0000000000001365 🔓

E5

Liang, S., Zhou, Y., Zhang, Q., Yu, S., & Wu, S. (2025). Ultra-processed foods and risk of all-cause mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies. Systematic Reviews, 14(1), 53. https://doi.org/10.1186/s13643-025-02800-8 🔓

🎧 Prefer to listen?

Listen to Are Ultra-Processed Foods Bad for You? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.

I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

If you’re new here, each week we explore body, mind, tech, and culture trends — especially when science and influence collide — to clarify what the strongest evidence actually supports.

And today is a bit different — stepping back after the first 24 to look at what actually holds up across them.

We’re surrounded by trends that sound scientific, feel persuasive, and spread quickly.

But something doesn’t quite add up.

Over the past 24 episodes, we’ve covered a wide range of health and wellness ideas.

Some promise precision — like genetic-based diets or continuous glucose monitoring (Episode 19 — DNA Diets; Episode 21 — CGM).
Others promise control — like digital detoxes, self-care strategies, or tracking your sleep and activity (Episode 11 — Digital Detox; Episode 12 — Self-Care & Burnout; Episode 2 — Sleep Trackers; Episode 10 — Wearables).

Some focus on biology — like the microbiome, cortisol, or GLP-1 medications (Episode 3 — Probiotics; Episode 15 — Cortisol; Episode 13 — GLP-1).
Others are shaped by culture and expectations — like influencer advice, money and wellbeing, or what’s considered “normal” in sexual health (Episode 16 — Influencer Advice; Episode 20 — Money & Happiness; Episode 24 — Sexual Activity).

And many sit right at the intersection — where visibility, marketing, and science overlap — like cold plunging, red-light therapy, detox cleanses, seed oils, and peptides (Episode 7 — Cold Plunging; Episode 8 — Red Light Therapy; Episode 18 — Detox Cleanses; Episode 22 — Seed Oils; Episode 23 — Peptides).

We’ve also looked at how information spreads — through AI-generated health content, mental health chatbots, and clinical research (Episode 5 — AI Health Content; Episode 6 — AI Mental Health; Episode 17 — Clinical Trials).

And across all of these — something interesting starts to show up.

Especially when something feels convincing before it’s fully supported.

Because in every episode, we’ve been asking one question:

Does this work?

But today, we’re asking something more useful.

What actually holds up — and what’s worth it?

📊THE SHIFT

Because when you look at any one trend on its own, it’s easy to get pulled into the details.

A study shows a benefit.
A headline makes a claim.
A story makes it feel convincing.

But across episodes, a different pattern starts to show up.

Most things don’t fall into “works” or “doesn’t work.”

They fall somewhere in between.

And the question shifts from:

Does this work?

to:

Is this worth it — for most people, most of the time?

🔬WHAT ACTUALLY HOLDS UP

When you step back, a few patterns show up again and again.

First — most trends contain some signal, but effects are usually small

Genetic-based diets lead to small, inconsistent changes (Episode 19 — DNA Diets).
Wearables can increase awareness or activity, but the effects are often modest and don’t last (Episode 10 — Wearables).
Digital detoxes can help — but effects are usually small and depend heavily on how changes are applied and sustained (Episode 11 — Digital Detox).

And with peptides, aside from collagen, most are not well studied in humans, are often unregulated, and may carry unknown risks (Episode 23 — Peptides).
Even with collagen, evidence suggests small, specific benefits under specific conditions — not broad or transformative effects (Episode 23 — Peptides).

Large, consistent effects are uncommon.

Second — more data doesn’t reliably change outcomes

Glucose monitoring can give detailed insight — but hasn’t been shown to consistently improve long-term outcomes in people without diabetes (Episode 21 — CGM).

Wearables can track more — but behavior change is often short-term (Episode 10 — Wearables).

Sleep tracking can increase awareness — but doesn’t consistently improve sleep, and for some people can increase anxiety about sleep (Episode 2 — Sleep Trackers).

More information can help you see more.

It doesn’t reliably change what happens next.

Third — context matters as much as, or more than, the tool

Self-care can support wellbeing — but it’s unlikely to resolve burnout without changes in workload, control, or environment (Episode 12 — Self-Care & Burnout).

Digital detoxes depend on what they replace and whether changes are realistic and sustainable (Episode 11 — Digital Detox).

And when it comes to deciding whether to participate in clinical trials, people don’t decide based on evidence alone — they weigh trust, clear information, practical demands, potential personal benefit, and contributing to science or future patients (Episode 17 — Clinical Trials).

The same approach can lead to very different outcomes depending on the context around it.

Fourth — simple rules are often more confident than the evidence

Detox cleanses sound compelling — but the body already has effective systems for processing and eliminating toxins, and there’s little evidence that commercial products enhance these processes in healthy people (Episode 18 — Detox Cleanses).

Sexual frequency is often treated as a measure of whether a sex life is normal — but satisfaction depends more on alignment and expectations than a specific number (Episode 24 — Sexual Activity).

And seed oils are often portrayed as harmful — but replacing saturated fats with unsaturated fats, including those commonly referred to as seed oils, is consistently associated with improved cardiovascular outcomes (Episode 22 — Seed Oils).

Simple rules feel clear.

But they often leave out what matters most.

Fifth — some effects are real, but often misunderstood

Placebo effects are real — but they tend to be modest for biological outcomes, and larger and more consistent for self-reported symptoms like pain or wellbeing (Episode 14 — Placebo Effects).

GLP-1 medications have meaningful effects during use — but weight regain is common after stopping, reflecting both underlying biology and the challenge of sustaining behavior change over time (Episode 13 — GLP-1).

Cortisol matters — but strong weight effects are seen in rare conditions with chronically high cortisol, not typical everyday stress (Episode 15 — Cortisol).

Real effects don’t always mean the outcome people expect.

Sixth — the biggest benefits are often the least visible

Daily movement, especially increasing activity from lower levels, shows consistent and meaningful health benefits (Episode 9 — Daily Steps).

Basic behaviors, done consistently over time, show up again and again.

But they’re rarely what gets attention.

And finally — sometimes the pattern is how we think, not just what we do

We’re drawn to certainty — even when the evidence is mixed (Episode 1 — Certainty in Health).

AI-generated health information can sound confident regardless of accuracy (Episode 5 — AI Health Content).

And influencer advice often reflects what is visible and relatable — not necessarily what is most supported by evidence (Episode 16 — Influencer Advice).

What feels convincing isn’t always what holds up.

🧠WHAT THIS MEANS

Across body, mind, tech, and culture trends, the same pattern holds.

Most ideas aren’t entirely right or wrong.

They sit somewhere in between.

With effects that are real — but often small, variable, and dependent on context.

But the way they’re presented often suggests something stronger, simpler, or more certain.

That gap is where confusion starts.

🧭THE TAKEAWAY

So what’s the takeaway?

Most trends aren’t wrong — they’re just not worth it.

Most trends contain some signal.

But very few are worth significant time, money, or attention
for most people.

Some provide insight.
Some help in specific situations.
Some are still evolving.

But very few deliver large, consistent, real-world impact.

Strong claims are easy to find.
Strong evidence is harder.

So the question isn’t just:

Does this work?

It’s:

Is this actually worth it — for me?

Because clarity doesn’t come from chasing every new idea.

It comes from understanding what actually holds up.

💭REFLECTION PROMPT

Something to reflect on…
When something sounds compelling,
are you responding to the evidence — or the way it’s presented?

📬OUTRO & CTA

If this episode helped you think differently about trends, follow Beyond the Buzz.

Each week, we take one body, mind, tech, or culture trend and look at what the evidence actually shows — what holds up, what doesn’t, and why the trend resonates.

You can explore the full transcript, the clarity poll, and the episode links in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Are Ultra-Processed Foods Bad for You?

📊 POLL

📚Previous Beyond the Buzz Episodes Referenced

1. How the Need for Certainty Shapes Health Decisions

2. How Sleep Trackers Shape What We Think About Sleep

3. What Probiotics Really Do for Gut Health

4. Do Daily Supplements Actually Increase Energy?

5. AI Health Answers and the Risk of Misinformation

6. AI Chatbots and Mental Health Support

7. Cold Plunging and Claims About Improving Mood

8. Red-Light Therapy and Exercise Recovery Claims

9. Do Daily Step Counts Really Matter?

10. Wearables

11. Digital Detoxes and Screen-Time Reduction: What the Evidence Shows

12. Self-Care and Burnout: What Actually Helps?

13. GLP-1 Medications and Weight Regain After Stopping

14. Placebo Effects in Wellness Practices Explained

15. Cortisol, Stress, and Weight Gain Claims

16. Influencer Health Advice and the Meaning of Authenticity

17. How Do People Decide to Join Clinical Trials?

18. Do Detox Cleanses Actually Help Your Body?

19. Can DNA Tests Really Personalize Your Diet?

20. How Much Does Money Really Affect Happiness?

21. Should You Use CGM Without Diabetes?

22. Should You Avoid Seed Oils?

23. Are Peptides Worth It for Muscle and Aging?

24. Is Your Sex Life Normal?

🎧 Prefer to listen?
Listen to Are Wellness Trends Worth Your Time and Money? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at how sexual activity, desire, satisfaction, and dysfunction change across adulthood — and what it really means when a bedroom feels “dead.”

Many people quietly wonder if their sex life is normal at their age or life stage.
Mixed messages online can make it hard to answer that question — and can lead to confusion, self-doubt, or a loss of confidence.

It can feel like everyone else is doing something different with their sex life — or doing it better.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Across social media and everyday conversations, you’ll see very different messages — from “dead bedroom” stories to expectations of constant, high-performing sex.

On one side, the idea of a “dead bedroom” is often tied to how often people think they should be having sex — and to the belief that desire naturally fades over time in long-term relationships.
In contrast, other messages suggest that sex should be frequent, intense, and consistently satisfying.

One widely cited statistic suggests that by 2024, only 37 percent of U.S. adults aged 18 to 64 reported having sex weekly (H1).
That means most people are having sex less than once a week.

So if you’re having sex once a week, you’re already above what most people report — and if it’s less frequent than that, it’s far from unusual.

Meanwhile, global data show that 59 percent of adults across 30 countries say they are happy with their romantic or sex life (H2) — which also means a substantial number of people are not.

But lower frequency and satisfaction can exist at the same time — and that’s not unusual.
This can make it hard to know what’s actually normal — or when something might be a problem.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

This episode is focused on general patterns across populations — not on diagnosing or managing specific medical conditions like erectile dysfunction or conditions affecting sexual desire or arousal.

Large population studies show that sexual activity has declined over time — over roughly the past two decades, especially among adults aged 18 to 44 (E1).
People are having sex less often and reporting fewer partners (E1).

Research on long-term relationships shows that maintaining sexual desire is complex (E2).
A systematic review — a study that reviews all available research on a topic — found that desire can change with factors like novelty, emotional connection, and stress (E2).

Studies also show that sexual satisfaction can shift over the course of a relationship (E3).
Some people report declines over time, while others maintain or improve satisfaction depending on communication and expectations (E3).

When it comes to sexual dysfunction — ongoing problems with desire, arousal, or satisfaction — estimates vary widely.
A meta-analysis — a study that combines results from multiple studies — found that how common sexual dysfunction appears depends heavily on how it’s defined and measured (E4).

And importantly, sexual activity does not stop in older adulthood (E5).
A systematic review found that many older adults remain sexually active, though patterns may change with health, partners, and life context (E5).

Across studies spanning younger adults through older adulthood, there is a wide range of what people report — from low to high desire and activity (E1)(E2)(E5).

What the research does not define clearly is a specific cutoff where lower frequency becomes a problem — that depends more on distress or mismatch than on a number alone (E4).

But importantly, less-than-weekly sex is common, while many people still report being satisfied with their romantic or sex life (H1)(H2).

🧠WHY THIS TREND RESONATES

So why do so many people find themselves asking if their sex life is normal?

Part of it is expectation.
People often assume there is a “normal” frequency tied to age or relationship length.

Part of it is visibility.
Social media often makes it easier to see more extreme experiences than the wide middle range that most people report.

And part of it comes down to comparison — something that’s all too easy when certain versions of sex are presented as normal across social media and pornography, rather than reflecting the wide range of real-life experiences.

When frequency drops — which happens in many relationships — it can feel like something is wrong, even when it reflects common patterns (E1)(E3).

Importantly, satisfaction does not always track with frequency.
People may have less sex but still feel content in their relationship (H2).

That gap between expectation and reality is where uncertainty grows — and where many people start to question whether their own experience is normal.

🧭THE TAKEAWAY

So what’s the takeaway?

Most adults are not having sex weekly, and many are still satisfied — so lower frequency alone doesn’t define a “dead” bedroom (H1)(H2).
That includes people having sex less than weekly — with a wide range of what that looks like in practice.

At the same time, a substantial number of people are not satisfied — and that matters (H2).
What the evidence consistently shows is that there’s a wide range of what people experience — across age and relationships — and there’s no single pattern that defines what it should look like for any one couple (E1)(E2)(E3)(E5).

It can be hard to tell whether change signals a problem or not.

But change doesn’t mean you have to settle. A satisfying sex life isn’t limited to a certain age or stage — and it’s reasonable to want that, even if it looks different over time.

And broader trends — like rising spending on sexual wellness products — suggest that many people are still interested in improving their sexual experiences (H3).

A bedroom tends to feel “dead” — not because of a specific number, but when there’s a persistent mismatch in desire or when one or both partners feel distressed by the change.

A more useful starting point is to look at whether both partners feel satisfied and aligned — not just how often sex is happening.

Your Evidence Edit moment:
A “dead bedroom” isn’t defined by how often you have sex.
Many adults have sex less than once a week (H1) — and many still report being satisfied with their sex life (H2).
But a substantial number of people are not satisfied — and that matters (H2).
Across adulthood, there’s a wide range of desire and activity — including in long-term relationships and older age (E2)(E3)(E5).
Even how sexual dysfunction is defined varies, which makes simple cutoffs unreliable (E4).
The evidence is consistent on one point — frequency alone does not define satisfaction or relationship quality (H2)(E4).
A bedroom tends to feel “dead” not because of a specific number, but because of how satisfied people feel with their sex life — not just how often sex happens (H2)(E4).
A quiet bedroom isn’t always a broken one.

And that distinction can change how you interpret your own experience.

💭REFLECTION PROMPT

Something to reflect on…
When you think about your own expectations, are they based on a number — or on whether your experience feels fulfilling to you?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: What have the first 24 episodes of Beyond the Buzz revealed?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

The Sex Recession: The Share of Americans Having Regular Sex Keeps Dropping. (2024). The Sex Recession: The Share of Americans Having Regular Sex Keeps Dropping. https://ifstudies.org/blog/the-sex-recession-the-share-of-americans-having-regular-sex-keeps-dropping

H2

Ipsos Love Life Satisfaction 2025. (2025). Ipsos Love Life Satisfaction 2025. https://www.ipsos.com/sites/default/files/ct/news/documents/2025-02/Ipsos%20-%20Love%20Life%20Satisfaction%202025.pdf

H3

Sex Toys Market Size, Share & Growth Analysis Report, 2030. (2024). Sex Toys Market Size, Share & Growth Analysis Report, 2030. https://www.grandviewresearch.com/industry-analysis/sex-toys-market

E1

Ueda, P., Mercer, C. H., Ghaznavi, C., & Herbenick, D. (2020). Trends in Frequency of Sexual Activity and Number of Sexual Partners Among Adults Aged 18 to 44 Years in the US, 2000-2018. JAMA Network Open, 3(6), e203833. https://doi.org/10.1001/jamanetworkopen.2020.3833 🔓

E2

Mark, K. P., & Lasslo, J. A. (2018). Maintaining Sexual Desire in Long-Term Relationships: A Systematic Review and Conceptual Model. The Journal of Sex Research, 55(4-5), 563-581. https://doi.org/10.1080/00224499.2018.1437592 🔒

E3

Schmiedeberg, C., & Schröder, J. (2016). Does Sexual Satisfaction Change With Relationship Duration? Archives of Sexual Behavior, 45(1), 99-107. https://doi.org/10.1007/s10508-015-0587-0 🔒

E4

Ramírez-Santos, J., Cristóbal-Cañadas, D., Parron-Carreño, T., Lozano-Paniagua, D., & Nievas-Soriano, B. J. (2024). The problem of calculating the prevalence of sexual dysfunction: a meta-analysis attending gender. Sexual Medicine Reviews, 12(2), 116-126. https://doi.org/10.1093/sxmrev/qead058 🔒

E5

Cameron, J., & Santos-Iglesias, P. (2024). Sexual Activity of Older Adults: A Systematic Review of the Literature. International Journal of Sexual Health, 36(2), 145-166. https://doi.org/10.1080/19317611.2024.2318388 🔓

🎧 Prefer to listen?
Listen to Is Your Sex Life Normal? Sex, Desire, Satisfaction, and Dead Bedrooms on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at peptides — often promoted for muscle growth, anti-aging, and recovery after exercise.
You’re seeing them across social media and in conversations about performance and longevity, often framed as a shortcut to better health or performance - things like strength or endurance.
But when messaging is mixed, it can be hard to tell what actually holds up — and what’s just momentum.
When the promises sound simple, the evidence is often more limited.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Peptides are gaining visibility across social media and online health spaces. (H1)
On TikTok alone, the hashtag #peptide shows over 300,000 posts, reflecting growing visibility and engagement. (H1)

At the same time, there’s a rapidly expanding commercial landscape around peptide use. (H2)
The global peptide therapeutics market is valued at over $130 billion USD and projected to more than double by 2034. (H2)

And alongside this growth, there are signals of rising demand beyond regulated use. (H3)
Labs are now conducting around 60,000 tests annually, reflecting growing demand for unregulated substances. (H3)

So this isn’t just a niche trend — it’s a large, visible, and evolving space.

At a basic level, peptides are short chains of amino acids — the building blocks of proteins — and some are already used in medicine.

But the ones showing up in these conversations don’t always look the same. Some are prescribed medications, like semaglutide or liraglutide used for weight loss, others are sold as supplements, like collagen peptides, and some are marketed online in less regulated ways.

A lot of the curiosity shows up in very practical questions — how they’re taken, where they come from, and what they’re actually supposed to do.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

For muscle strength and recovery after exercise, much of the available research focuses on collagen peptides — the most studied in this area, but not representative of all peptides promoted online.
Collagen peptides are small protein fragments that may support connective tissue in the body. (E1)(E2)

Systematic reviews — studies that combine results from many trials — suggest that when collagen peptides are paired with long-term training, there may be modest improvements in strength and recovery outcomes. (E1)(E2)

But these effects are generally small and often depend on consistent exercise alongside supplementation. (E1)(E2)

For anti-aging claims, especially related to the skin, there is some evidence that oral collagen may improve skin elasticity and hydration. (E3)
These findings come from pooled studies, but results vary and tend to be modest rather than transformative. (E3)

In practical terms, that means changes can be measurable — but they’re unlikely to match the kinds of dramatic outcomes often described online.

When we move beyond collagen to other peptides — particularly those marketed for anti-aging or performance — the evidence becomes much less clear.
This includes many peptides people are asking about online, where high-quality human evidence is often limited or missing.

A major scientific statement on hormones and aging highlights that many interventions affecting hormone systems — including some peptides — show inconsistent benefits and may carry risks. (E4)

In studies of growth hormone — sometimes linked to peptide use — results show limited functional benefit in healthy older adults, along with increased adverse effects. (E5)

So while some peptide uses have targeted evidence for specific outcomes, broader claims about anti-aging or improved exercise performance are not consistently supported across high-quality evidence.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

This is part of a bigger shift toward personalized health.

Peptides feel targeted, scientific, and aligned with the idea of fine-tuning the body.

They also fit into the idea that aging, recovery, and performance can be controlled if you find the right tool.

And when people are already investing time in fitness or health routines, the idea of an added edge can be compelling.

🧭THE TAKEAWAY

So what’s the takeaway?

Here’s what holds up: some peptide uses — like collagen for skin or joint support — have modest, context-specific evidence. (E1)(E2)(E3)
What we don’t know is whether broader claims about muscle growth, anti-aging, or recovery translate into meaningful, consistent benefits in healthy people, and some approaches may involve risk. (E4)(E5)

It’s easy to feel confident — even when the evidence is still limited.

Your Evidence Edit moment:
Peptides aren’t broadly supported for muscle strength, aging, or improved exercise performance.
This conversation is about peptides promoted for muscle growth, anti-aging, and recovery after exercise — particularly in otherwise healthy people.
The evidence shows that some specific uses, like collagen, have modest, targeted benefits — but evidence for broader claims remains limited or inconsistent, with some potential risks.
Most research focuses on narrow outcomes or specific populations — not broad real-world use.
Strong claims about improved exercise performance or anti-aging often go beyond what high-quality evidence can support.
Narrow benefits are supported — broad promises are not.

If you’re considering peptides, start by asking what specific outcome you’re targeting — and whether there’s clear evidence for that exact use.

💭REFLECTION PROMPT

Something to reflect on…
When something feels highly targeted and scientific, what makes it easier to trust — and what helps you step back and ask what actually holds up?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: What’s normal for sex across your life?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

TikTok. (n.d.). Creative Center — #peptide Trending Hashtag on TikTok, see #peptide analytics. TikTok.
Metric value at reporting, from
• Hashtag: https://ads.tiktok.com/business/creativecenter/hashtag/peptide/pc/en?countryCode=US&period=7 (Value at reporting: 303K Overall; observed April 11, 2026)

Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2

Fortune Business Insights. (2026). Peptide Therapeutics Market Size, Industry Share, Forecast, 2034. Fortune Business Insights. https://www.fortunebusinessinsights.com/industry-reports/peptide-therapeutics-market-101420

H3

The Guardian. (2026). “’Traceability is vital’: labs test thousands of unregulated substances amid peptide craze”. The Guardian. https://www.theguardian.com/science/2026/apr/06/labs-testing-thousands-of-unregulated-substances-amid-peptide-craze

E1

Bischof, K., Moitzi, A. M., Stafilidis, S., & König, D. (2024). Impact of Collagen Peptide Supplementation in Combination with Long-Term Physical Training on Strength, Musculotendinous Remodeling, Functional Recovery, and Body Composition in Healthy Adults: A Systematic Review with Meta-analysis. Sports Medicine, 54(11), 2865–2888. https://doi.org/10.1007/s40279-024-02079-0 🔒

E2

Khatri, M., Naughton, R. J., Clifford, T., & Harper, L. D. (2021). The effects of collagen peptide supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise: a systematic review. Amino Acids, 53(11), 1493–1506. https://doi.org/10.1007/s00726-021-03072-x 🔒

E3

Pu, S.-Y., Huang, Y.-L., Pu, C.-M., Kang, Y.-N., Hoang, K. D., Chen, K.-H., & Chen, C. (2023). Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients, 15(9), 2080. https://doi.org/10.3390/nu15092080 🔓

E4

Cappola, A. R., Auchus, R. J., El-Hajj Fuleihan, G., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023). Hormones and Aging: An Endocrine Society Scientific Statement. The Journal of Clinical Endocrinology & Metabolism, 108(8), 1835–1874. https://doi.org/10.1210/clinem/dgad225 🔓

E5

Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007). Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly. Annals of Internal Medicine, 146(2), 104–115. https://doi.org/10.7326/0003-4819-146-2-200701160-00005 🔒

🎧 Prefer to listen?
Listen to Are Peptides Worth It for Muscle, Anti-Aging, and Recovery? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at seed oils and health — a topic that’s gained a lot of attention, often framed as something to avoid or eliminate.
You’re likely hearing mixed messages in everyday conversations, online, and even in food choices.
When advice conflicts, it can take time and energy to sort through what matters.
Simple rules can feel convincing — even when the evidence doesn’t fully support them.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Seed oils — like soybean, corn, sunflower, and canola oils used in cooking and packaged foods — are often discussed as harmful, especially online.
They’re often described as inflammatory or linked to chronic disease, with advice to avoid them entirely.

This is not a small or niche topic.
A recent survey found that 28% of people report actively avoiding seed oils — roughly 1 in 4 of us. (H1)
That’s a sizable portion of people actively changing their food choices.

There’s also a large and growing industry behind these products.
The Vegetable Oil Market was valued at almost 400 billion USD in 2025, and is expected to reach over 420 billion USD in 2026. (H2)

So what we’re seeing is strong opinions, widespread behavior change, and a major global market.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, it helps to define a key term — systematic review.
A systematic review is a study that reviews all available research on a topic.

Across multiple systematic reviews and meta-analyses, the evidence does not support the claim that seed oils are broadly harmful. (E1)

In fact, when looking at linoleic acid — a type of omega-6 fat commonly found in seed oils — higher intake has been associated with a lower risk of coronary heart disease in long-term observational studies. (E2)

Linoleic acid intake has also been linked to lower overall mortality in pooled analyses of population studies. (E3)

When researchers compare different fats, replacing saturated fats — typically solid fats like butter — with unsaturated fats from vegetable oils tends to improve blood lipid profiles, including lowering LDL cholesterol. (E4)

LDL cholesterol — often called “bad cholesterol” — is linked to heart disease risk.

Another common concern is inflammation.
But controlled trials summarized in systematic reviews do not show that higher linoleic acid intake increases markers of inflammation in healthy people. (E5)

At a broader level, umbrella reviews — which synthesize multiple systematic reviews — show that different edible oils have varying effects, but do not support the idea that all seed oils are harmful — meaning consistently linked to higher risk of heart disease or death. (E1)

That said, most of this evidence comes from population studies and controlled trials in specific contexts — not every real-world scenario.
Diet patterns, food processing, and overall lifestyle all play a role, and no single ingredient explains health outcomes on its own.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

One possible reason is that simple rules can feel easier to follow than complex evidence. “Cut this out” is often clearer than “it depends on context.”

There’s also a growing focus on food processing and ingredient lists, which may make seed oils an easy target.

And when people are trying to make healthier choices, clear boundaries can feel reassuring — even if the underlying evidence is more nuanced.

🧭THE TAKEAWAY

So what’s the takeaway?

Here’s what holds up: across multiple high-quality reviews, seed oils — particularly those high in linoleic acid — are not consistently linked to harm and are often associated with favorable cardiovascular markers when used in place of saturated fats. What we don’t know is how individual oils, processing, and overall diet patterns interact in real-world settings over time. (E1)(E2)(E3)(E4)(E5)

It’s easy to feel confident — even when the evidence doesn’t support it.

Your Evidence Edit moment:
Seed oils are not clearly harmful — and no specific seed oil has been consistently shown to cause harm in high-quality human studies, even though they’re often framed that way.
This conversation is really about how different types of dietary fats relate to long-term health outcomes.
Across systematic reviews and meta-analyses, the evidence does not show increased inflammation or harm from typical intake, and in some cases shows associations with improved cardiovascular markers when replacing saturated fats. (E1)(E2)(E3)(E4)(E5)
At the same time, most research looks at dietary patterns over time, not single foods in isolation.
Strong claims about eliminating one ingredient often go beyond what the evidence can support.
Clear rules feel simple — but evidence rarely is.

Evidence is clear that focusing on the overall pattern matters most — instead of eliminating seed oils, replace saturated fats like butter with unsaturated oils as part of a balanced diet.

💭REFLECTION PROMPT

Something to reflect on…
When you hear a clear rule about food — what helps you decide whether it reflects the full picture, or just part of it?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Do peptides work for performance and aging?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

IFIC Spotlight Survey: Americans’ Perceptions Of Seed Oils. (2025). IFIC Spotlight Survey: Americans’ Perceptions Of Seed Oils. https://ific.org/wp-content/uploads/2025/04/IFIC-2025-Spotlight-Survey-Seed-Oils.pdf

H2

Mordor Intelligence. (2026). Vegetable Oil Market Size & Share Analysis. Mordor Intelligence. https://www.mordorintelligence.com/industry-reports/vegetable-oil-market

E1

Voon, P. T., Ng, C. M., Ng, Y. T., Wong, Y. J., Yap, S. Y., Leong, S. L., Yong, X. S., & Lee, S. W. H. (2024). Health Effects of Various Edible Vegetable Oil: An Umbrella Review. Advances in Nutrition, 15(9), 100276. https://doi.org/10.1016/j.advnut.2024.100276 🔓

E2

Farvid, M. S., Ding, M., Pan, A., Sun, Q., Chiuve, S. E., Steffen, L. M., Willett, W. C., & Hu, F. B. (2014). Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Circulation, 130(18), 1568-1578. https://doi.org/10.1161/CIRCULATIONAHA.114.010236 🔓

E3

Li, J., Guasch-Ferré, M., Li, Y., & Hu, F. B. (2020). Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. The American Journal of Clinical Nutrition, 112(1), 150-167. https://doi.org/10.1093/ajcn/nqz349 🔓

E4

Schwingshackl, L., Bogensberger, B., Benčič, A., Knüppel, S., Boeing, H., & Hoffmann, G. (2018). Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis. Journal of Lipid Research, 59(9), 1771-1782. https://doi.org/10.1194/jlr.P085522 🔓

E5

Johnson, G. H., & Fritsche, K. (2012). Effect of Dietary Linoleic Acid on Markers of Inflammation in Healthy Persons: A Systematic Review of Randomized Controlled Trials. Journal of the Academy of Nutrition and Dietetics, 112(7), 1029-1041.e15. https://doi.org/10.1016/j.jand.2012.03.029 🔒

🎧 Prefer to listen?
Listen to Should You Avoid Seed Oils? Evidence on Seed Oils and Health on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at continuous glucose monitoring — or CGM — and whether it offers meaningful insight for metabolic health beyond diabetes. CGM is a wearable device that tracks glucose levels in real time through a small sensor under the skin.

Increasingly, people are using these devices to understand how food, exercise, and daily habits affect their bodies. It can feel like a way to gain control and clarity in a complex health landscape.

But with so many interpretations of glucose spikes, patterns, and “optimal” ranges online, it can be hard to know what actually holds up.
For some people, when more data feels empowering, it can also make everyday decisions about food and habits more complicated.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

Across social media and wellness spaces, CGM is showing up more frequently right now.

More than seven million people are using one CGM system globally, highlighting how widespread this technology has become (H1).

At the same time, the market is growing quickly. The global CGM device market was valued at over 13 billion US dollars in 2025 and is projected to exceed 41 billion dollars by 2033 (H2).

CGM has a primary role in diabetes management. But beyond that, a new narrative is starting to take hold.

CGMs are increasingly being used to “optimize” metabolism — using real-time glucose data to track how the body responds to food and personalize choices.

The idea is simple and compelling: if you can see how your body responds, you can make better decisions.

And that promise — personalized insight, immediate feedback — is a powerful one.

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

A systematic review — a study that combines all available research — looked at CGM use in people without diabetes (E1).

It found that while CGM can provide detailed glucose patterns, these insights have not been consistently shown to improve outcomes like body weight, blood sugar markers, or overall metabolic health in people without diabetes (E1).

And that distinction matters.

Another systematic review and meta-analysis of randomized controlled trials — a high-quality study design — examined whether CGM helps change behavior (E2).

It showed that CGM can support behavior change in some cases, particularly when combined with structured programs, but these effects are often short-term, variable, and not consistent across groups (E2).

A scoping review — a broad summary of existing research — found that CGM may increase awareness and engagement with health behaviors, but this does not always translate into sustained or meaningful change (E3).

Research also suggests that while CGM has potential applications in wellness and sports, its role in healthy individuals is not yet clearly defined (E4).

In the context of heart disease and related risk, a systematic review found that while CGM may help guide lifestyle decisions, the evidence supporting long-term benefits in people without diabetes remains limited (E5).

So overall, the evidence points to growing interest and potential — but also important uncertainty about long-term impact.

In people without diabetes, it’s still unclear how to interpret specific glucose changes or what they mean for long-term health (E1)(E2)(E5).

That also raises a common question — are glucose spikes in people without diabetes actually harmful?
Right now, it’s still unclear whether typical fluctuations within normal ranges in otherwise healthy individuals translate into long-term health risk (E1)(E5).

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

There may be something deeper going on here.

If you’ve ever seen your own data change in real time, it’s easy to see why this catches attention.

CGM offers something many health tools don’t — immediate, personalized feedback.

For many people, that can feel more relevant and more actionable.

It also fits with a broader shift toward self-tracking and personalization in health and wellness (E4).

And for many people, seeing numbers change after a meal or workout can create a sense of cause and effect — even when the long-term meaning of those changes isn’t fully clear (E3).

Part of the appeal seems to be that combination — visibility, personalization, and control — which may help explain why this trend is gaining traction.

🧭THE TAKEAWAY

So what’s the takeaway?

Here’s what holds up: CGM can provide detailed glucose data and can support awareness or short-term behavior change in some people (E1)(E2). What we don’t have is consistent evidence that this leads to meaningful long-term health benefits in people without diabetes (E1)(E2)(E5).

It can feel empowering to see data, yet unclear what it really means.

If you don’t have diabetes and are using — or considering using — a CGM, it may be worth pausing to consider whether the data you see actually requires a change in your behavior (E1)(E5).

Your Evidence Edit moment:
In people without diabetes, tracking your glucose in real time has not been consistently shown to improve health outcomes.
Continuous glucose monitoring (CGM) is also used by people without diabetes to track how food and lifestyle affect their glucose.
The evidence shows that while CGM can increase awareness and sometimes support behavior change, the overall impact on long-term health outcomes in people without diabetes is mixed and still limited (E1)(E2)(E5).
More data can inform decisions, but it doesn’t guarantee better outcomes.

Seeing patterns is easy.

Interpreting them is the hard part.

💭REFLECTION PROMPT

Something to reflect on…
When you see health data about your body, what helps you decide whether it’s meaningful — or just interesting?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Seed Oils and Health

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1

Abbott. (2026). Revolutionizing Diabetes Care to Make a Difference. Abbott. https://www.abbott.com/en-us/careers/working-with-us/changing-lives/revolutionizing-diabetes-care-to-make-a-difference

H2

Grand View Research. (2025). Continuous Glucose Monitoring Devices Market Report, 2033. Grand View Research. https://www.grandviewresearch.com/industry-analysis/continuous-glucose-monitoring-market

E1

Liao, X., Li, Y., Tang, S., Xiao, Y., Yu, X., Huang, R., & Zhong, T. (2026). Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis. European Journal of Medical Research, 31(1), 397. https://doi.org/10.1186/s40001-026-03920-0 🔓

E2

Richardson, K. M., Jospe, M. R., Bohlen, L. C., Crawshaw, J., Saleh, A. A., & Schembre, S. M. (2024). The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials. International Journal of Behavioral Nutrition and Physical Activity, 21(1), 145. https://doi.org/10.1186/s12966-024-01692-6 🔓

E3

Jospe, M. R., Richardson, K. M., Saleh, A. A., Bohlen, L. C., Crawshaw, J., Liao, Y., Konnyu, K., & Schembre, S. M. (2024). Leveraging continuous glucose monitoring as a catalyst for behaviour change: a scoping review. International Journal of Behavioral Nutrition and Physical Activity, 21, 74. https://doi.org/10.1186/s12966-024-01622-6 🔓

E4

Holzer, R., Bloch, W., & Brinkmann, C. (2022). Continuous Glucose Monitoring in Healthy Adults—Possible Applications in Health Care, Wellness, and Sports. Sensors, 22(5), 2030. https://doi.org/10.3390/s22052030 🔓

E5

Ahmed, N., Ali, M. F. E., Mohamed, M. N. H., & Rabih, M. R. M. (2025). Use of Continuous Glucose Monitoring in Non-diabetic Individuals for Cardiovascular Prevention: A Systematic Review of Its Impact on Guiding Lifestyle Interventions. Cureus, 17(10), e94460. https://doi.org/10.7759/cureus.94460 🔓

🎧 Prefer to listen?
Listen to Should You Use CGM Without Diabetes? on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at money, happiness, and wellbeing.

Many people are trying to figure out how much money really matters for a good life.
But mixed messages about income and happiness can leave people feeling unsure and frustrated.

It sounds simple — but the answer may not be.

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

This question shows up everywhere — in conversations, headlines, and everyday decisions.

Globally, money is one of the most commonly cited reasons for unhappiness.
Among people who report being unhappy, 58% say their finances are the main cause (H1).

At the same time, there’s a massive industry built around improving wellbeing.
The global wellness market has reached almost $7 trillion, after years of steady growth (H2).

So on one side, we see financial stress as a major source of distress.
On the other, we see a rapidly expanding market promising better wellbeing.

And somewhere in between is the question many people are asking:
Does having more money actually make us happier?

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

First, changes in income do matter for mental health —but the effect is not always straightforward.
A systematic review — a study that combines results from many studies — found that increases in income are generally linked to improvements in mental health and wellbeing (E1).

Second, how people feel about their finances matters as much as income itself.
A meta-analysis — a statistical summary of multiple studies — shows that financial satisfaction is strongly linked to overall life satisfaction (E2).

This means it’s not just how much you earn — but how secure or satisfied you feel.

Third, inequality plays a role.
Higher income inequality within a society is associated with lower subjective wellbeing overall (E3).

So it’s not only individual income — it’s how your finances fit in with those around you. The broader context matters too.

Fourth, financial stress is consistently linked to poorer mental health.
A systematic review found that financial stress is associated with higher risk of depression in adults (E4).

And finally, when researchers look broadly at what increases happiness, money is one factor among many — not the defining one.
A review of experimental studies shows that many different factors influence happiness, including social connection and daily experiences (E5).
At the same time, one large study found that the feeling of wellbeing — how people feel day to day — tends to rise with income, even beyond earlier proposed thresholds (E6).

So overall, income does matter — but its impact depends on context, perception, and other life factors.

🧠WHY THIS TREND RESONATES

This connects to something many people feel every day.

Money is closely tied to basic needs, security, and future planning.
It affects housing, food, healthcare, and stability.

So when finances feel uncertain, the emotional impact can be immediate.

And as income rises, spending often rises too — which means financial pressure doesn’t always disappear at higher income levels.

At the same time, money is often used as a simple way to measure success.
It’s visible, comparable, and easy to track.

But wellbeing is more complex.
It includes emotional, social, and psychological factors that aren’t captured by income alone.

So it makes sense that people look for a clear number —
even if the reality is more layered.

🧭THE TAKEAWAY

So what’s the takeaway?

The evidence suggests that money does influence happiness, especially through reducing financial stress and supporting stability (E1)(E4).
But the relationship is not linear or complete — how people feel about their finances and broader life context also play a major role (E2)(E3)(E5).

It can feel like there should be a clear number to aim for, but the evidence does not support a single income number that determines happiness — and money alone doesn’t explain how people feel.

Your Evidence Edit moment:
There is strong evidence that more money is linked to higher wellbeing — but it doesn’t buy happiness on its own. Income can improve mental health and daily experience, especially by reducing financial stress, but it does not fully determine how people feel (E1)(E4)(E5). How satisfied people feel with their finances — and the broader social context they live in — also shapes wellbeing in meaningful ways (E2)(E3).
More money helps — but it’s not the whole story.

Reducing financial stress where possible is important, but daily experiences — like how you spend your time — and social connection also shape wellbeing.

💭REFLECTION PROMPT

Something to reflect on…
When you think about your own wellbeing, what feels most connected to it — income, financial security, or something else?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: Is Continuous Glucose Monitoring Useful Without Diabetes?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
Ipsos. (2025, March 18). Global attitudes to happiness and quality of life. Ipsos. https://www.ipsos.com/en/global-attitudes-to-happiness-and-quality-of-life 🔓

H2
Global Wellness Institute. (2025, November 19). The global wellness economy hits a record $6.8 trillion and is forecast to reach $9.8 trillion by 2029. Global Wellness Institute. https://globalwellnessinstitute.org/press-room/press-releases/the-global-wellness-economy-hits-a-record-6-8-trillion-and-is-forecast-to-reach-9-8-trillion-by-2029/ 🔓

E1
Thomson, R. M., Igelström, E., Purba, A. K., Shimonovich, M., Thomson, H., McCartney, G., Reeves, A., Leyland, A., Pearce, A., & Katikireddi, S. V. (2022). How do income changes impact on mental health and wellbeing for working-age adults? A systematic review and meta-analysis. The Lancet Public Health, 7(6), e515-e528. https://doi.org/10.1016/S2468-2667(22)00058-5 🔓

E2
Ngamaba, K. H., Armitage, C., Panagioti, M., & Hodkinson, A. (2020). How closely related are financial satisfaction and subjective well-being? Systematic review and meta-analysis. Journal of Behavioral and Experimental Economics, 85, 101522. https://doi.org/10.1016/j.socec.2020.101522 🔒

E3
Ngamaba, K. H., Panagioti, M., & Armitage, C. J. (2018). Income inequality and subjective well-being: a systematic review and meta-analysis. Quality of Life Research, 27(3), 577-596. https://doi.org/10.1007/s11136-017-1719-x 🔓

E4
Guan, N., Guariglia, A., Moore, P., Xu, F., & Al-Janabi, H. (2022). Financial stress and depression in adults: A systematic review. PLoS One, 17(2), e0264041. https://doi.org/10.1371/journal.pone.0264041 🔓

E5
Folk, D., & Dunn, E. (2024). How Can People Become Happier? A Systematic Review of Preregistered Experiments. Annual Review of Psychology, 75, 467-493. https://doi.org/10.1146/annurev-psych-022423-030818 🔓

E6
Killingsworth, M. A. (2021). Experienced well-being rises with income, even above $75,000 per year. Proceedings of the National Academy of Sciences, 118(4). https://doi.org/10.1073/pnas.2016976118 🔓

🎧 Prefer to listen?
Listen to How Much Money Affects Happiness and Wellbeing on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer

This post includes the full transcript of this week’s Beyond the Buzz episode, followed by the clarity poll and full evidence.

🎧INTRO

Welcome to Beyond the Buzz — where curiosity meets clarity.
I’m Dr. Tara Moroz, scientist and communicator with decades of experience translating complex human research into clear, evidence-informed insight.

Today we’re looking at direct-to-consumer genetic testing and personalized diet recommendations.

Many people are trying to make better food choices using new tools and information.
But mixed messages about genetics and nutrition can make it hard to know what actually helps.

It sounds promising — but does the science really match the marketing?

Let’s take a closer look together — starting with what’s driving the buzz.

📊THE BUZZ

This trend is everywhere right now.

Over 56 million people have their genetic information in major direct-to-consumer testing databases (H1) — roughly the population of a large country.

And it’s not just about curiosity anymore.

There’s a substantial market built around using that genetic data to guide food choices.
The global personalized nutrition market was valued at over 15 billion US dollars in 2025 (H2).

That includes diet plans, supplements, and apps that claim to tailor recommendations to your DNA.

The idea behind it is simple and appealing.
Your genes influence how your body responds to nutrients.
So if you know your genes, you can personalize your diet.

But that raises an important question.
How much can these tools actually deliver — and what does the evidence really show?

🧾RECEIPT CHECK

Let’s check the evidence — our kind of receipt check.

This is the moment to pause and ask the questions that matter — what’s the evidence, what’s the source, and how do we know?

🔬WHAT THE EVIDENCE SHOWS

Here’s what the evidence shows.

Several systematic reviews — studies that combine results from many studies — have looked at whether genotype-based advice changes health or behavior (E1).

Overall, the findings are mixed.
Some studies show small improvements in behavior, like modest changes in diet or physical activity (E1).
But these effects are often small and not consistent across studies (E1).

Another systematic review of randomized controlled trials — where people are randomly assigned to groups — found that personalized nutrition advice can improve dietary intake in some cases (E2).
But again, the effects are generally modest and vary between individuals (E2).

When we look specifically at direct-to-consumer genetic testing, the evidence suggests that receiving genetic results does not lead to large or lasting behavior changes for most people (E3).

There is also an important question about scientific validity — whether the genetic markers used are reliably linked to meaningful nutrition outcomes.
A review of evaluation frameworks found that many gene–diet relationships lack strong or consistent evidence (E4).

Professional guidance reflects this uncertainty.
A consensus report from the Academy of Nutrition and Dietetics notes that genetic testing may have a role in nutrition care, but it should be used carefully and alongside other clinical information (E5).

So while the concept is biologically plausible, the current evidence does not support strong or consistent benefits for most people.

In practical terms, these tests may offer some insight, but they’re unlikely to dramatically change health outcomes or provide a fully personalized diet on their own.

🧠WHY THIS TREND RESONATES

So why does this trend resonate?

It taps into something very human.

People want answers that feel specific and personal.
Generic advice like “eat well” can feel vague or hard to apply.

Genetic information offers a sense of precision.
It feels scientific, individualized, and actionable.

There’s also a sense of control.
If your DNA holds the key, it can feel like you’re unlocking a personalized roadmap.

And in a crowded nutrition space, personalization stands out.

🧭THE TAKEAWAY

So what’s the takeaway?

The evidence suggests that genotype-based nutrition advice can lead to small changes in behavior, but results are mixed and inconsistent (E1)(E2).
There is little evidence that direct-to-consumer genetic testing alone leads to meaningful or lasting behavior change (E3).
Many gene–diet links remain weakly established (E4).

It’s understandable to want answers that feel uniquely yours.

Your Evidence Edit moment:
DNA-based diet advice sounds precise — but the evidence is much less clear.
The evidence shows small effects at best — and results are inconsistent.
Current research shows small or variable changes in behavior (E1)(E2), and many gene–diet links are weakly established (E4).
This means personalized nutrition based on DNA is still developing, not definitive science.
Personalization sounds precise, but evidence shows a more uncertain picture.

Clarity comes from understanding both potential and limits.

If you’re considering using genetic-based nutrition advice, it may help to treat it as one piece of information — not a complete answer — and to focus first on well-established nutrition habits that apply broadly.

💭REFLECTION PROMPT

Something to reflect on…
When something feels highly personalized and scientific, what makes it feel trustworthy to you?

📬OUTRO & CTA

If you found this useful, follow Beyond the Buzz and share it with a friend who likes a little science with their scroll.
You can also explore the full transcript, the clarity poll, and evidence in The Evidence Edit.

Until next time, stay curious — and stay kind to your mind.

This is Beyond the Buzz — cutting through the hype, because evidence is empowering.

Next week: How Much Does Money Really Affect Happiness?

📊 POLL

📚REFERENCES — What’s the Hype (H1–H#) / What’s the Evidence (E1–E#)

🔓 Open Access |🔒Paywalled

H1
ISOGG Wiki. (n.d.). Autosomal DNA testing comparison chart (compiled by Tim Janzen). ISOGG. Metric value at reporting (observed March 20, 2026), from • Number of people in the database (as of 16 Mar 2026): https://isogg.org/wiki/Autosomal_DNA_testing_comparison_chart (Value at reporting: 56,592,196) Note: This value is a constructed summary derived from individual company database counts listed on the source page. Note: Platform engagement metrics are dynamic, real-time cumulative values and change over time.

H2
Fortune Business Insights. (2025). Personalized Nutrition Market Size, Share, Growth Report, 2034. Fortune Business Insights. https://www.fortunebusinessinsights.com/personalized-nutrition-market-106054 🔒

E1
King, A., Graham, C. A.-M., Glaister, M., Da Silva Anastacio, V., Pilic, L., & Mavrommatis, Y. (2023). The efficacy of genotype-based dietary or physical activity advice in changing behavior to reduce the risk of cardiovascular disease, type II diabetes mellitus or obesity: a systematic review and meta-analysis. Nutrition Reviews, 81(10), 1235-1253. https://doi.org/10.1093/nutrit/nuad001 🔒

E2
Jinnette, R., Narita, A., Manning, B., McNaughton, S. A., Mathers, J. C., & Livingstone, K. M. (2021). Does Personalized Nutrition Advice Improve Dietary Intake in Healthy Adults? A Systematic Review of Randomized Controlled Trials. Advances in Nutrition, 12(3), 657-669. https://doi.org/10.1093/advances/nmaa144 🔓

E3
Stewart, K. F. J., Wesselius, A., Schreurs, M. A. C., Schols, A. M. W. J., & Zeegers, M. P. (2018). Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis. Journal of Community Genetics, 9(1), 1-18. https://doi.org/10.1007/s12687-017-0310-z 🔓

E4
Keathley, J., Garneau, V., Zavala-Mora, D., Heister, R. R., Gauthier, E., Morin-Bernier, J., Green, R., & Vohl, M.-C. (2021). A Systematic Review and Recommendations Around Frameworks for Evaluating Scientific Validity in Nutritional Genomics. Frontiers in Nutrition, 8, 789215. https://doi.org/10.3389/fnut.2021.789215 🔓

E5
Braakhuis, A., Monnard, C. R., Ellis, A., & Rozga, M. (2021). Consensus Report of the Academy of Nutrition and Dietetics: Incorporating Genetic Testing into Nutrition Care. Journal of the Academy of Nutrition and Dietetics, 121(3), 545-552. https://doi.org/10.1016/j.jand.2020.04.002 🔒

🎧 Prefer to listen?
Listen to Can DNA Tests Personalize Your Diet? Evidence on Genetic Nutrition Advice on the Beyond the Buzz website — or follow Beyond the Buzz in your favourite podcast app.

Educational content only. This publication does not provide individualized medical, psychological, or professional advice.
Full disclaimer: beyondthebuzzmedia.com/disclaimer